Datasets:
ChatDOC
/
OCRFlux-pubtabnet-cross

Dataset card Data Studio Files
xet
 Community
1
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
table_fragment_1
stringlengths
43
8.42k
table_fragment_2
stringlengths
39
8.21k
fea2d6904a028719194392e2bd0776357c362f76c59e27cb9106f847e1c3b3ab.png
complex
<table><tr><td>Variables</td><td>Case (<i>n</i> = 97) #(%)</td><td>Control (<i>n</i> = 194) #(%)</td><td>Crude OR (95 % CI)</td></tr><tr><td colspan="4">Ever heard of PITC</td></tr><tr><td> Yes</td><td>54 (55.7)</td><td>170 (87.6)</td><td>1</td></tr><tr><td> No</td><td>43 (44.3)</td><td>24 (12.4)</td><td>5.64 (3.14,10....
<table><tr><td>Variables</td><td>Case (n = 97) #(%)</td><td>Control (n = 194) #(%)</td><td>Crude OR (95 % CI)</td></tr><tr><td colspan="4">Ever heard of PITC</td></tr><tr><td>Yes</td><td>54 (55.7)</td><td>170 (87.6)</td><td>1</td></tr><tr><td>No</td><td>43 (44.3)</td><td>24 (12.4)</td><td>5.64 (3.14,10.13)a</td></tr><t...
<table><tr><td colspan="4">nefits of PITC</td></tr><tr><td>Yes</td><td>58 (59.8)</td><td>185 (95.4)</td><td>1</td></tr><tr><td>No</td><td>39 (40.2)</td><td>9 (4.6)</td><td>13.82 (6.32,30.23)a</td></tr><tr><td colspan="4">PITC can affect health service utilization by patients</td></tr><tr><td>No</td><td>81 (83.5)</td><t...
d6d342cecaf59c1c0ba1eea954733bdbb638bd5b7b0f0edb715a5bb2f6f80f9a.png
complex
<table><tr><td>Name</td><td colspan="3">2010</td><td colspan="3">2013</td><td colspan="3">Difference</td></tr><tr><td></td><td>h-core citations</td><td>h-index</td><td>Bh-index</td><td>h-core citations</td><td>h-Index</td><td>Bh-Index</td><td>h-core citations</td><td>h-Index</td><td>Bh-Index</td></tr><tr><td>Boyer PD</...
<table><tr><td>Name</td><td colspan="3">2010</td><td colspan="3">2013</td><td colspan="3">Difference</td></tr><tr><td></td><td>h-core </td><td>h-</td><td>B</td><td>h-core cit</td><td>h</td><td>Bh-I</td><td>h-core citations</td><td>h-I</td><td></td></tr></table>
<table><tr><td></td><td>citations</td><td>index</td><td>h-index</td><td>ations</td><td>-Index</td><td>ndex</td><td></td><td>ndex</td><td>Bh-Index</td></tr><tr><td>Boyer PD</td><td>3103</td><td>29</td><td>48</td><td>3484</td><td>30</td><td>50</td><td>381</td><td>1</td><td>2</td></tr><tr><td>Kohn W</td><td>3215</td><td>2...
6fd1eae5d071fc5ac4398a3c104be291a423e2f691c89e2e7128ddb8caf42077.png
simple
<table><tr><td>abbreviation</td><td>muscle name</td><td>maximum isometric force (<i>F</i><sub>iso</sub>, N)</td><td>optimal fibre length (L<sub>fopt</sub>, m)</td><td>tendon slack length (<i>L</i><sub>tsl</sub>, m)</td><td>pennation angle (&#176;)</td></tr><tr><td>IC</td><td>M. iliotibialis cranialis</td><td>889</td><t...
<table><tr><td>abbreviation</td><td>muscle name</td><td>maximum isometric force (Fiso, N)</td><td>optimal fibre length (Lfopt, m)</td><td>tendon slack length (Ltsl, m)</td><td>pennation angle (°)</td></tr><tr><td>IC</td><td>M. iliotibialis cranialis</td><td>889</td><td>0.174</td><td>0.0451</td><td>0</td></tr><tr><td>IL...
<table><tr><td>IFI</td><td>M. iliofemoralis internus</td><td>410</td><td>0.041</td><td>0.0533</td><td>0</td></tr><tr><td>FCM</td><td>M. flexor cruris medialis</td><td>1109</td><td>0.036</td><td>0.435</td><td>35</td></tr><tr><td>FCLP</td><td>M. flexor cruris lateralis pars pelvica</td><td>544</td><td>0.24</td><td>0.2449...
13fb856f35b681de7a732ffe0d860ae0b1f6f22a843939cb73ef96fe9ae85879.png
simple
<table><tr><td></td><td>Group ofCOPD+PAH (n = 12)</td><td>Group of COPD (n = 36)</td><td>Group of HS (n = 15)</td></tr><tr><td>Sex, M/F</td><td>11/1</td><td>32/4</td><td>9/6</td></tr><tr><td>Age, Years</td><td>70.8 (6.7)</td><td>67.6 (9.2)</td><td>58 (9.2)</td></tr><tr><td>Smoking, pack-years</td><td>27 (7)</td><td>25 ...
<table><tr><td></td><td>Group ofCOPD+PAH (n = 12)</td></tr><tr><td>Sex, M/F</td><td>11/1</td></tr><tr><td>Age, Years</td><td>70.8 (6.7)</td></tr><tr><td>Smoking, pack-years</td><td>27 (7)</td></tr><tr><td>FEV1%</td><td>39.35 (11.45)</td></tr><tr><td>FVC%</td><td>64.89 (14.90)</td></tr><tr><td>FEV1/FVC %</td><td>46.95 (...
<table><tr><td>Group of COPD (n = 36)</td><td>Group of HS (n = 15)</td></tr><tr><td>32/4</td><td>9/6</td></tr><tr><td>67.6 (9.2)</td><td>58 (9.2)</td></tr><tr><td>25 (6)</td><td>0</td></tr><tr><td>48.13 (18.04)</td><td>98.05 (11.65)</td></tr><tr><td>69.39 (19.1)</td><td>95.07 (13.34)</td></tr><tr><td>54.27 (12.46)</td>...
6b5b20697c998265141f5be2c82f0ec32da5e36b49c1ea0c512a5f1467b52e6c.png
simple
<table><tr><td>Predictors (all T1 variables)</td><td>Odds Ratio</td><td>95% CI</td></tr><tr><td>Independent</td><td></td><td></td></tr><tr><td>Neighborhood crime</td><td>0.91</td><td>0.75&#8211;1.10</td></tr><tr><td>Neighborhood drug selling/use</td><td>1.39</td><td>1.16&#8211;1.66</td></tr><tr><td>Noxious neighborhood...
<table><tr><td>Predictors (all T1 variables)</td></tr><tr><td>Independent</td></tr><tr><td>Neighborhood crime</td></tr><tr><td>Neighborhood drug selling/use</td></tr><tr><td>Noxious neighborhood</td></tr><tr><td>Controls</td></tr><tr><td>Age</td></tr><tr><td>Sex (Ref = Male)</td></tr><tr><td>SES</td></tr><tr><td>Occasi...
<table><tr><td>Odds Ratio</td><td>95% CI</td></tr><tr><td></td><td></td></tr><tr><td>0.91</td><td>0.75–1.10</td></tr><tr><td>1.39</td><td>1.16–1.66</td></tr><tr><td>1.03</td><td>0.90–1.19</td></tr><tr><td></td><td></td></tr><tr><td>1.51</td><td>1.22–1.85</td></tr><tr><td>0.64</td><td>0.43–0.95</td></tr><tr><td>1.08</td...
446f109488018ddcaf1d0ae8037ad5bf897e49272fac52aad8468a8ee1704fcc.png
simple
<table><tr><td></td><td>Sense primer (5&#8242; to 3&#8242;)</td><td>Anti-sense primer (5&#8242; to 3&#8242;)</td></tr><tr><td>Human CCL19</td><td>CCAACTCTGAGTGGCACCAA</td><td>TGAACACTACAGCAGGCACC</td></tr><tr><td>Human CCL21</td><td>TGGCCTCTTACTCACCCTCT</td><td>GCCTCTTGATCCCCTTAGCC</td></tr><tr><td>Human CCR7</td><td>G...
<table><tr><td></td><td>Sense primer (5′ to 3′)</td><td>Anti-sense primer (5′ to 3′)</td></tr><tr><td>Human CCL19</td><td>CCAACTCTGAGTGGCACCAA</td><td>TGAACACTACAGCAGGCACC</td></tr><tr><td>Human CCL21</td><td>TGGCCTCTTACTCACCCTCT</td><td>GCCTCTTGATCCCCTTAGCC</td></tr><tr><td>Human CCR7</td><td>GCCTACGACGTCACCTACAG</td>...
<table><tr><td></td><td>Sense primer (5′ to 3′)</td><td>Anti-sense primer (5′ to 3′)</td></tr><tr><td>Osterix</td><td>AGAGGAGAGACTCGGGACAG</td><td>GAGTTGTTGAGTCCCGCAGA</td></tr></table>
75d16279b2bec0ded3f83b37684470838f063b6a2f03d74e9c90abcaaf2ba5b8.png
complex
<table><tr><td></td><td colspan="2">ASD (<i>n</i> = 9)</td><td colspan="2">Neurotypical (<i>n</i> = 9)</td><td colspan="2">Group difference</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td><i>t</i>(16)</td><td><i>p</i></td></tr><tr><td>Chronological age (years)</td><td>13.67</td><td>1.94</td><t...
<table><tr><td></td><td colspan="2">ASD (n = 9)</td><td colspan="2">Neurotypical (n = 9)</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Chronological age (years)</td><td>13.67</td><td>1.94</td><td>14.44</td><td>1.13</td></tr><tr><td>WASI vocabulary</td><td>52</td><td>10.99</td><td>63...
<table><tr><td colspan="2">Group difference</td></tr><tr><td>t(16)</td><td>p</td></tr><tr><td>-1.04</td><td>0.31</td></tr><tr><td>-2.74</td><td>0.01</td></tr><tr><td>-1.51</td><td>0.15</td></tr><tr><td>-2.43</td><td>0.03</td></tr><tr><td>ADOS</td><td></td></tr><tr><td>8.44</td><td><0.001</td></tr><tr><td>7.24</td><td><...
f2e378a909776ec26040345fc1c00f24f196cc836b3f816e80b4a9531b3fc243.png
simple
<table><tr><td>Characteristics</td><td>ORT corner users, n(%)</td><td>ORT corner non-users, n(%)</td><td>p value</td></tr><tr><td><i>Age:</i></td><td></td><td></td><td>0.4905</td></tr><tr><td> 18-19 years</td><td>9(8)</td><td>11(9)</td><td></td></tr><tr><td> 20-29 years</td><td>48(44)</td><td>63(53)</td><td></td></tr><...
<table><tr><td>Characteristics</td><td>ORT corner users, n(%)</td><td>ORT corner non-users, n(%)</td><td>p value</td></tr><tr><td>Age:</td><td></td><td></td><td>0.4905</td></tr><tr><td>18-19 years</td><td>9(8)</td><td>11(9)</td><td></td></tr><tr><td>20-29 years</td><td>48(44)</td><td>63(53)</td><td></td></tr><tr><td>30...
<table><tr><td>Characteristics</td><td>ORT corner users, n(%)</td><td>ORT corner non-users, n(%)</td><td>p value</td></tr><tr><td>employee</td><td>3)</td><td>2)</td><td></td></tr><tr><td>Students</td><td>0(0)</td><td>2(2)</td><td></td></tr><tr><td>Other</td><td>2(2)</td><td>2(2)</td><td></td></tr><tr><td>Religion: Musl...
bde201776502d52b21f3ec163ef107e10dad05bf9ed35fe1e1f1f27ba4cc5f3d.png
complex
<table><tr><td></td><td></td><td></td><td colspan="2">Schizophrenia</td><td colspan="2">Controls</td></tr><tr><td></td><td></td><td></td><td>Amplitudes (&#956;V)</td><td>Latency (ms)</td><td>Amplitudes (&#956;V)</td><td>Latency (ms)</td></tr><tr><td>Emotional syllables</td><td>Angry</td><td>F3</td><td>-1.77 &#177; 1.20...
<table><tr><td></td><td></td><td></td><td>Schizophrenia</td></tr><tr><td></td><td></td><td></td><td>Amplitudes (μV)</td></tr><tr><td>Emotional syllables</td><td>Angry</td><td>F3</td><td>-1.77 ± 1.20</td></tr><tr><td></td><td></td><td>Fz</td><td>-1.94 ± 1.23</td></tr><tr><td></td><td></td><td>F4</td><td>-1.85 ± 1.30</td...
<table><tr><td>Schizophrenia</td><td colspan="2">Controls</td></tr><tr><td>Latency (ms)</td><td>Amplitudes (μV)</td><td>Latency (ms)</td></tr><tr><td>245.27 ± 57.25</td><td>-2.55 ± 1.12</td><td>251.00 ± 51.81</td></tr><tr><td>239.33 ± 54.31</td><td>-2.69 ± 1.19</td><td>247.93 ± 55.60</td></tr><tr><td>244.87 ± 52.14</td...
1fbb3f9563534e4efd4a5f52b4fd41ec0e6f59e0ff336550ce7ae451c0f8d773.png
simple
<table><tr><td></td><td>N = 137 patients (23 residents)</td></tr><tr><td>Physician's Use of Obesity Counseling</td><td></td></tr><tr><td> % Counseled about Obesity (n)</td><td>85.4 (117)</td></tr><tr><td> Mean Number of Counseling Practices<sup>1 </sup>(SD) (18 Items total)</td><td>5.3 (4.6)</td></tr><tr><td>5As</td><t...
<table><tr><td></td><td>N = 137 patients (23 residents)</td></tr></table>
<table><tr><td>Physician's Use of Obesity Counseling</td><td></td></tr><tr><td>% Counseled about Obesity (n)</td><td>85.4 (117)</td></tr><tr><td>Mean Number of Counseling Practices1 (SD) (18 Items total)</td><td>5.3 (4.6)</td></tr><tr><td>5As</td><td></td></tr><tr><td>Mean Number of Assess2 Practices (SD) (6 items)</td...
42c760b7cb710a43e2b0d216f54e288fbe75014ebfa9fa77f120eb7ff8ff19ee.png
simple
<table><tr><td>Characteristics</td><td>No. of patients (%)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td> Median (range)</td><td>71.0 (65.0-81.0)</td></tr><tr><td>ECOG performance status</td><td></td></tr><tr><td> 0-1</td><td>108 (81.2)</td></tr><tr><td> &#8805; 2</td><td>25 (18.8)</td></tr><tr><td>BMI (kg/m<s...
<table><tr><td>Characteristics</td></tr><tr><td>Age (years)</td></tr><tr><td>Median (range)</td></tr><tr><td>ECOG performance status</td></tr><tr><td>0-1</td></tr><tr><td>≥ 2</td></tr><tr><td>BMI (kg/m2)</td></tr><tr><td>< 30</td></tr><tr><td>≥ 30</td></tr><tr><td>WIC</td></tr><tr><td>≥ 1</td></tr><tr><td>< 1</td></tr>...
<table><tr><td>No. of patients (%)</td></tr><tr><td></td></tr><tr><td>71.0 (65.0-81.0)</td></tr><tr><td></td></tr><tr><td>108 (81.2)</td></tr><tr><td>25 (18.8)</td></tr><tr><td></td></tr><tr><td>96 (72.2)</td></tr><tr><td>37 (27.8)</td></tr><tr><td></td></tr><tr><td>52 (39.1)</td></tr><tr><td>81 (60.9)</td></tr><tr><td...
f2a2b149df841e9a9fa715106e3d7306d16484d9ebf75d810e30b75782cc5749.png
simple
<table><tr><td>Number of Procedures</td><td>&lt; 200h</td><td>&gt; 200h</td><td>p value</td></tr><tr><td>History Takings in Initial Patient Care</td><td>136.905</td><td>363.800</td><td>0.001075</td></tr><tr><td>Non-cast immobilizations</td><td>19.360</td><td>63.577</td><td>0.005303793</td></tr><tr><td>Cast immobilizati...
<table><tr><td>Number of Procedures</td><td>< 200h</td><td>> 200h</td><td>p value</td></tr></table>
<table><tr><td>History Takings in Initial Patient Care</td><td>136.905</td><td>363.800</td><td>0.001075</td></tr><tr><td>Non-cast immobilizations</td><td>19.360</td><td>63.577</td><td>0.005303793</td></tr><tr><td>Cast immobilizations</td><td>32.811</td><td>102.160</td><td>0.000295235</td></tr><tr><td>Simple sutures</td...
424021d6368b352afd689ebc3fee08edde4c08fcdb995c030c54feba80a3882c.png
complex
<table><tr><td></td><td>Adolescent population*</td><td colspan="4">Adolescents with emergency admission(s) for injury between 10 and 19 years of age, n (row %)</td></tr><tr><td>Characteristics</td><td>Total</td><td>Total</td><td>Adversity</td><td>Accidents only</td><td>Other causes</td></tr><tr><td>All</td><td>3 254 04...
<table><tr><td></td><td>Adolescent population*</td><td colspan="4">Adolescents with emergency admission(s) for injury between 10 and 19 years of age, n (row %)</td></tr><tr><td>Characteristics</td><td>Total</td><td>Total</td><td>Adversity</td><td>Accidents only</td><td>Other causes</td></tr><tr><td>All</td><td>3 254 04...
<table><tr><td></td><td>Adolescent population*</td><td colspan="4">Adolescents with emergency admission(s) for injury between 10 and 19 years of age, n (row %)</td></tr><tr><td>Characteristics</td><td>Total</td><td>Total</td><td>Adversity</td><td>Accidents only</td><td>Other causes</td></tr><tr><td>Girls (years)</td><t...
8ad63402e9e860b5c6649718c283f7d707973a3af0e6fddfa377c93904f499ae.png
simple
<table><tr><td>Index</td><td>Weekdays</td><td>Weekend</td><td><i>p</i></td></tr><tr><td>Bedtime (HH:MM)</td><td>11:46 p.m. &#177; 87.2</td><td>00:12 a.m. &#177; 102.0</td><td>&lt;0.001</td></tr><tr><td>Wake-up Time (HH:MM)</td><td>06:32 a.m. &#177; 80.6</td><td>07:26 a.m. &#177; 105.0</td><td>&lt;0.001</td></tr><tr><td...
<table><tr><td>Index</td><td>Weekdays</td><td>Weekend</td><td>p</td></tr><tr><td>Bedtime (HH:MM)</td><td>11:46 p.m. ± 87.2</td><td>00:12 a.m. ± 102.0</td><td><0.001</td></tr><tr><td>Wake-up Time (HH:MM)</td><td>06:32 a.m. ± 80.6</td><td>07:26 a.m. ± 105.0</td><td><0.001</td></tr></table>
<table><tr><td>Index</td><td>Weekdays</td><td>Weekend</td><td>p</td></tr><tr><td>Sleep Midpoint (HH:MM)</td><td>03:09 a.m. ± 77.2</td><td>03:49 a.m. ± 96.4</td><td><0.001</td></tr><tr><td>Time in Bed (min)</td><td>406 ± 65.9</td><td>434 ± 75.4</td><td><0.001</td></tr><tr><td>Total Sleep Time (min)</td><td>354 ± 60.1</t...
5e223c30277d424960b6407b4cd933599a1ecd6ea374ccb69ce80091bcb49dbc.png
complex
<table><tr><td rowspan="2" colspan="2">Month</td><td colspan="2">Cross-validation (%)</td><td rowspan="2">Allometry (%)</td><td rowspan="2">Influential landmark</td></tr><tr><td>&#9794;</td><td>&#9792;</td></tr><tr><td rowspan="2">JAN/2009</td><td>Hilltop</td><td>81</td><td>93</td><td>10.470*</td><td>#10 and #17</td></...
<table><tr><td rowspan="2" colspan="2">Month</td><td colspan="2">Cross-validation (%)</td><td rowspan="2">Allometry (%)</td><td rowspan="2">Influential landmark</td></tr><tr><td>♂</td><td>♀</td></tr><tr><td rowspan="2">JAN/2009</td><td>Hilltop</td><td>81</td><td>93</td><td>10.470*</td><td>#10 and #17</td></tr><tr><td>L...
<table><tr><td rowspan="2">JUL/2012</td><td>Hilltop</td><td>83</td><td>90</td><td>6.909*</td><td>#2 and #9</td></tr><tr><td>Lowland</td><td>92</td><td>95</td><td>5.924*</td><td>#9 and #10</td></tr><tr><td rowspan="2">JAN/2013</td><td>Hilltop</td><td>96</td><td>100</td><td>8.433*</td><td>#9 and #10</td></tr><tr><td>Lowl...
a916db0a3aa6d08b66556657e9a431344374cbb70061cff8a2566b05dc756d61.png
simple
<table><tr><td>Country</td><td>Sample name</td><td>Latitude</td><td>Longitude</td></tr><tr><td>Poland</td><td>A</td><td>53&#176; 50&#8242;02.83&#8242;&#8242;N</td><td>21&#176; 03&#8242;30.36&#8242;&#8242;E</td></tr><tr><td>Poland</td><td>H</td><td>54&#176; 23&#8242;21.42&#8242;&#8242;N</td><td>18&#176; 28&#8242;42.18&#...
<table><tr><td>Country</td><td>Sample name</td><td>Latitude</td><td>Longitude</td></tr><tr><td>Poland</td><td>A</td><td>53° 50′02.83′′N</td><td>21° 03′30.36′′E</td></tr><tr><td>Poland</td><td>H</td><td>54° 23′21.42′′N</td><td>18° 28′42.18′′E</td></tr><tr><td>Germany</td><td>B</td><td>52° 13′09.87′′N</td><td>11° 42′25.1...
<table><tr><td>Country</td><td>Sample name</td><td>Latitude</td><td>Longitude</td></tr><tr><td>Sweden</td><td>F</td><td>58° 52′20.04′′N</td><td>14° 53′56.79′′E</td></tr><tr><td>Sweden</td><td>K</td><td>64° 36′27.31′′N</td><td>20° 57′04.32′′E</td></tr><tr><td>Ireland</td><td>G</td><td>53° 35′24.27′′N</td><td>08° 03′33.6...
8625bac6b418b8901b9c6fa6bdf825992f7d98c8e7baec4afb892436df5045dd.png
simple
<table><tr><td></td><td>ExpressHMM</td><td>ANTM</td></tr><tr><td>Probe sensitivity</td><td>65%</td><td>44%</td></tr><tr><td>Novel probes predicted</td><td>65%</td><td>49%</td></tr><tr><td>Overlap exon Sensitivity</td><td>58%</td><td>58%</td></tr><tr><td>Novel transfrags predicted</td><td>27%</td><td>58%</td></tr><tr><t...
<table><tr><td></td><td>ExpressHMM</td></tr><tr><td>Probe sensitivity</td><td>65%</td></tr><tr><td>Novel probes predicted</td><td>65%</td></tr><tr><td>Overlap exon Sensitivity</td><td>58%</td></tr><tr><td>Novel transfrags predicted</td><td>27%</td></tr><tr><td>5' Splice site sensitivity</td><td>16%</td></tr><tr><td>3' ...
<table><tr><td>ANTM</td></tr><tr><td>44%</td></tr><tr><td>49%</td></tr><tr><td>58%</td></tr><tr><td>58%</td></tr><tr><td>9%</td></tr><tr><td>13%</td></tr></table>
60f3df316538da8b59d3b8ed37f405e8fc869162530b99356997166c95e33962.png
simple
<table><tr><td></td><td>N</td><td>% of sample (N = 201)</td><td>95% C.I.</td></tr><tr><td>&lt; 2 weeks</td><td>57</td><td>28.4</td><td>22.3 &#8211; 35.1</td></tr><tr><td>2 weeks</td><td>42</td><td>20.9</td><td>15.5 &#8211; 27.2</td></tr><tr><td>1 month</td><td>31</td><td>15.4</td><td>10.7 &#8211; 21.2</td></tr><tr><td>...
<table><tr><td></td><td>N</td><td>% of sample (N = 201)</td><td>95% C.I.</td></tr><tr><td>< 2 weeks</td><td>57</td><td>28.4</td><td>22.3 – 35.1</td></tr><tr><td>2 weeks</td><td>42</td><td>20.9</td><td>15.5 – 27.2</td></tr><tr><td>1 month</td><td>31</td><td>15.4</td><td>10.7 – 21.2</td></tr><tr><td>2 month</td><td>15</t...
<table><tr><td>s</td><td></td><td>5</td><td></td></tr><tr><td>3 months</td><td>16</td><td>7.9</td><td>4.6 – 12.5</td></tr><tr><td>4 months</td><td>40</td><td>19.9</td><td>14.6 – 26.1</td></tr><tr><td>Total</td><td>201</td><td>100.0</td><td></td></tr></table>
4479d863f6d895a877955c417bf0f56846606738f53642aba960a4a0bb5c7bcf.png
complex
<table><tr><td>Diagnosis</td><td>Parasite</td><td>Early [n (%)]</td><td>Peak [n (%)]</td><td>Late [n (%)]</td><td>Total [n (%)]</td><td>P value<sup>1</sup></td></tr><tr><td rowspan="4">Microscopy</td><td><i>P. vivax</i></td><td>9 (1.7)</td><td>13 (2.3)</td><td>3 (0.5)</td><td>25 (1.5)</td><td>0.066</td></tr><tr><td><i>...
<table><tr><td>Diagnosis</td><td>Parasite</td><td>Early [n (%)]</td><td>Peak [n (%)]</td><td>Late [n (%)]</td><td>Total [n (%)]</td><td>P value1</td></tr><tr><td rowspan="3">Microscopy</td><td>P. vivax</td><td>9 (1.7)</td><td>13 (2.3)</td><td>3 (0.5)</td><td>25 (1.5)</td><td>0.066</td></tr><tr><td>P. falciparum</td><td...
<table><tr><td>Microscopy</td><td>Total</td><td>9 (1.7)</td><td>13 (2.3)</td><td>3 (0.5)</td><td>25 (1.5)</td><td>0.066</td></tr><tr><td rowspan="4">nRT-PCR</td><td>P. vivax</td><td>95 (18.4)</td><td>152 (26.3)</td><td>105 (17.9)</td><td>352 (21.0)</td><td>0.001</td></tr><tr><td>P. falciparum</td><td>0</td><td>14 (2.4)...
73462abd091d13084520236e16cf879d21b9ee66f20ac3c87efb7ccc4e7d43b0.png
simple
<table><tr><td>Tandem repeat Family</td><td>Repeat Length</td><td>GC Content (%)</td><td>Genome Coverage (%)<sup>a</sup></td><td>Consensus Sequence<sup>b</sup></td><td>Distribution</td></tr><tr><td>pBuM189</td><td>189</td><td>29</td><td>0.039</td><td>GCAAAAGACTCCGTCAATTA GAAAACAAAAAATGTTATAGTTTTGAGGATTAACC GGCAAAAACCGT...
<table><tr><td>Tandem repeat Family</td><td>Repeat Length</td><td>GC Content (%)</td><td>Genome Coverage (%)a</td></tr><tr><td>pBuM189</td><td>189</td><td>29</td><td>0.039</td></tr><tr><td>DbuTR198</td><td>198</td><td>34</td><td>0.027</td></tr></table>
<table><tr><td>Consensus Sequenceb</td><td>Distribution</td></tr><tr><td>GCAAAAGACTCCGTCAATTA GAAAACAAAAAATGTTATAGTTTTGAGGATTAACC GGCAAAAACCGTATTATTTGTTATAT GATTTCTGTATGGAATACCGTTTTAGAA GCGTCTTTTATCGTATTACTCAGATATATCT TAAGATTTAGCATAATCTAAGAACTTTT TGAAATATTCACATTTGTCCA</td><td>D. buzzatii cluster species D. mojavensis</...
ebe4a23bd73164f427e2b14b826b42163b1a5062f4048e5cbd2ee067173f97a4.png
simple
<table><tr><td>Policosanol (Chemical formula)</td><td>Percent</td></tr><tr><td>Docosan-1-ol (C<sub>22</sub>-OH)</td><td>1.52 &#177; 0.24</td></tr><tr><td>Tricosan-1-ol (C<sub>23</sub>-OH)</td><td>2.12 &#177; 0.39</td></tr><tr><td>Tetracosan-1-ol (C<sub>24</sub>-OH)</td><td>2.02 &#177; 0.50</td></tr><tr><td>Hexacosan-1-...
<table><tr><td>Policosanol (Chemical formula)</td><td>Percent</td></tr><tr><td>Docosan-1-ol (C22-OH)</td><td>1.52 ± 0.24</td></tr><tr><td>Tricosan-1-ol (C23-OH)</td><td>2.12 ± 0.39</td></tr><tr><td>Tetracosan-1-ol (C24-OH)</td><td>2.02 ± 0.50</td></tr><tr><td>Hexacosan-1-ol (C26 -OH)</td><td>2.50 ± 0.16</td></tr><tr><t...
<table><tr><td>Policosanol (Chemical formula)</td><td>Percent</td></tr><tr><td>Octacosan-1-ol (C28-OH)</td><td>75.44 ± 2.41</td></tr><tr><td>Nonacosan-1-ol (C29-OH)</td><td>2.55 ± 0.62</td></tr><tr><td>Triacontan-1-ol (C30-OH)</td><td>8.61 ± 1.20</td></tr><tr><td>Dotriacontan-1-ol (C32-OH)</td><td>3.34 ± 0.56</td></tr>...
9bf4c8bbfb474d9692c8f2aa1df1712b593f0036895c3843ce4d8da7e0984a72.png
complex
<table><tr><td rowspan="2" colspan="2">Experimental groups</td><td colspan="7">Lipid parameters (mg/dL)</td></tr><tr><td>TC</td><td>TG</td><td>VLDL-c</td><td>HDL-c</td><td>LDL-c</td><td>LDL/HDL</td><td>CT/HDL</td></tr><tr><td colspan="2">HC rats + dH<sub>2</sub>O</td><td>156.09 &#177; 0.92</td><td>141.01 &#177; 0.63</t...
<table><tr><td colspan="2">Experimental groups</td><td colspan="7">Lipid parameters (mg/dL)</td></tr></table>
<table><tr><td colspan="2">Experimental groups</td><td>TC</td><td>TG</td><td>VLDL-c</td><td>HDL-c</td><td>LDL-c</td><td>LDL/HDL</td><td>CT/HDL</td></tr><tr><td colspan="2">HC rats + dH2O</td><td>156.09 ± 0.92</td><td>141.01 ± 0.63</td><td>28.21 ± 0.73</td><td>31.05 ± 0.48*</td><td>109.28 ± 0.49</td><td>5.87 ± 0.05</td>...
037cc4376798a2fb6e0766765fc7dc00daaa15b1116c3277b70667d4e0680289.png
complex
<table><tr><td>Anatomical region</td><td colspan="4">Healthy</td><td rowspan="3">CS1 LWP LI</td><td rowspan="3">CS2 RWP LI</td><td rowspan="3">CS3 RWP LI</td></tr><tr><td></td><td colspan="2">LWP LI (<i>n</i> = 12)</td><td colspan="2">RWP LI (<i>n</i> = 6)</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>...
<table><tr><td>Anatomical regi</td><td colspan="4">He</td><td>C</td><td>CS2</td><td>CS3 R</td></tr></table>
<table><tr><td>on</td><td colspan="4">althy</td><td rowspan="3">S1 LWP LI</td><td rowspan="3"> RWP LI</td><td rowspan="3">WP LI</td></tr><tr><td></td><td colspan="2">LWP LI (n = 12)</td><td colspan="2">RWP LI (n = 6)</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>SMG</td><td>0.41</td...
43ee5178e5264d3f886d9fead9d3d245a273969596925176ff40a540aded17cc.png
complex
<table><tr><td></td><td>Based on parent ATS report</td><td>Based on child ATS report</td></tr><tr><td rowspan="4">MVPA of trips during the times reported by the parent</td><td><i>U</i> = 390.5, <i>p</i> = 0.02*</td><td><i>U</i> = 596.5, <i>p</i> = 0.02*</td></tr><tr><td>ATS trips (<i>n</i> = 99) 2.46 min (2.83)</td><td...
<table><tr><td></td><td>Based on parent ATS report</td><td>Based on child ATS report</td></tr><tr><td>MVPA of trips during the times reported by the parent</td><td>U = 390.5, p = 0.02*</td><td>U = 596.5, p = 0.02*</td></tr></table>
<table><tr><td rowspan="3">MVPA of trips during the times reported by the parent</td><td>ATS trips (n = 99) 2.46 min (2.83)</td><td>ATS trips (n = 128) 2.40 min (2.68)</td></tr><tr><td>Non-ATS trips (n = 13) 0.76 min (0.95)</td><td>Non-ATS trips (n = 15) 0.81 min (0.87)</td></tr><tr><td>Missing trips = 170 (60.3%)</td>...
38f5ee99424668e3b3bc605be7492a3648c6b143adcec1546a10e1011d781b14.png
simple
<table><tr><td>Case</td><td>Sex, Age (years)</td><td>Previous operations</td><td>Fusion length</td><td>ASF</td><td>Cause and further treatment</td></tr><tr><td>1</td><td>M, 62</td><td>Yes</td><td>2</td><td>Yes</td><td>Patient had persitant back pain postoperatively and paresthesia in the lower extremity. MRI showed an ...
<table><tr><td>Case</td><td>Sex, Age (years)</td><td>Previous operations</td><td>Fusion length</td><td>ASF</td><td>Cause and further treatment</td></tr><tr><td>1</td><td>M, 62</td><td>Yes</td><td>2</td><td>Yes</td><td>Patient had persitant back pain postoperatively and paresthesia in the lower extremity. MRI showed an ...
<table><tr><td></td><td> 65</td><td>o</td><td></td><td>es</td><td>luded a pedicle fracture causing a transient paresis of the hip flexion requiring immediate screw removal and nerve exploration. There was no nerve root damage. The fusion was elongated by 2 levels. The muscle regained full function in the follow-ups.</t...
0865258b7b2524a578496a86378429ecdc2c8ea011d395305bf22e2b15533703.png
complex
<table><tr><td></td><td></td><td colspan="2">Leisure-time physical activity</td><td rowspan="2"><i>p</i></td></tr><tr><td></td><td>Total <i>N</i> (%)</td><td>Yes (%)</td><td>No (%)</td></tr><tr><td>Feel too tired</td><td>62 (63.3)</td><td>59.3</td><td>64.8</td><td>0.612</td></tr><tr><td>Chronic kidney disease</td><td>5...
<table><tr><td></td><td></td><td colspan="2">Leisure-time physical activity</td><td rowspan="2">p</td></tr><tr><td></td><td>Total N (%)</td><td>Yes (%)</td><td>No (%)</td></tr><tr><td>Feel too tired</td><td>62 (63.3)</td><td>59.3</td><td>64.8</td><td>0.612</td></tr></table>
<table><tr><td></td><td></td><td colspan="2">Leisure-time physical activity</td><td rowspan="2">p</td></tr><tr><td></td><td>Total N (%)</td><td>Yes (%)</td><td>No (%)</td></tr><tr><td>Chronic kidney disease</td><td>50 (51.0)</td><td>51.9</td><td>50.7</td><td>0.919</td></tr><tr><td>Hemodialysis treatment</td><td>47 (48....
ecdb33cee3f620ddb2b4788dc222ddf48aaaf29515d37f307d2c25d11d038eb3.png
simple
<table><tr><td>Active ingredient</td><td>Abbreviation/Pharmaceutical preparation</td><td>Trade name (US)</td><td>Manufacturer</td><td>Approval status (US)</td><td>Notes</td></tr><tr><td>Methylphenidate hydrochloride</td><td>MPH-MR08 (modified-release preparation)</td><td>Ritalin<sup>R </sup>LA (using SODAS delivery sys...
<table><tr><td>Active ingredient</td><td>Abbreviation/Pharmaceutical preparation</td><td>Trade name (US)</td><td>Manufacturer</td><td>Approval status (US)</td><td>Notes</td></tr><tr><td>Methylphenidate hydrochloride</td><td>MPH-MR08 (modified-release preparation)</td><td>RitalinR LA (using SODAS delivery system develop...
<table><tr><td>Mixed amphetamine salts</td><td>MAS (immediate and extended release formulations</td><td>AdderallR, AdderallR XR</td><td>Shire</td><td>Available in US</td><td>Unlikely to be approved in Europe</td></tr><tr><td>ModafinilSuccessor compound: Armodafinil</td><td>MOD; dopamine reuptake inhibitor; effects on n...
ccb5ff98bcb6fa650fdf009ca73b77b6f7e570fc0858b4a3ae084053cf42f313.png
complex
<table><tr><td colspan="3">Current UK Vaccination Against Invasive Meningococcal Disease</td></tr><tr><td>Vaccine (Serogroups)</td><td>Year Introduced into schedule</td><td>Age given</td></tr><tr><td>B</td><td>2015</td><td>8 weeks, 16 weeks, 1 year</td></tr><tr><td>C</td><td>1999</td><td>1 year<sup>a</sup></td></tr><tr...
<table><tr><td colspan="2">Current UK Vaccination Against Invasive Meningococcal Disease</td></tr><tr><td>Vaccine (Serogroups)</td><td>Year Introduced into schedule</td></tr><tr><td>B</td><td>2015</td></tr><tr><td>C</td><td>1999</td></tr><tr><td>ACWY</td><td>2015</td></tr></table>
<table><tr><td>Current UK Vaccination Against Invasive Meningococcal Disease</td></tr><tr><td>Age given</td></tr><tr><td>8 weeks, 16 weeks, 1 year</td></tr><tr><td>1 yeara</td></tr><tr><td>14 years, University students 19–25 years</td></tr></table>
3f967922169b6c2effa838b3999c82ab63bde3c9dd7b2e65cac2ad3b8eafeb31.png
complex
<table><tr><td>Cell type</td><td>AR expression (method)</td><td>Reference</td></tr><tr><td colspan="3">Stem cells and progenitor cells</td></tr><tr><td>Hematopoietic stem cell</td><td>Yes (RT-PCR, IF)</td><td>(33, 34)</td></tr><tr><td>Common myeloid progenitor</td><td>Yes (RT-PCR)</td><td>(33)</td></tr><tr><td>Common l...
<table><tr><td>Cell type</td><td>AR expression (method)</td><td>Reference</td></tr><tr><td colspan="3">Stem cells and progenitor cells</td></tr><tr><td>Hematopoietic stem cell</td><td>Yes (RT-PCR, IF)</td><td>(33, 34)</td></tr><tr><td>Common myeloid progenitor</td><td>Yes (RT-PCR)</td><td>(33)</td></tr><tr><td>Common l...
<table><tr><td>Mature B cell</td><td>Not expressed (IHC, WB)</td><td>(37, 43)</td></tr><tr><td colspan="3">Other</td></tr><tr><td>Thymic epithelial cells</td><td>Yes (IF)</td><td>(44)</td></tr><tr><td>Bone marrow stromal cells</td><td>Yes (IHC, WB)</td><td>(37, 43)</td></tr></table>
aeccd4ea5bffc0c0db74080028bb7a37738670a5692458455dbf6131545e2045.png
simple
<table><tr><td>Name</td><td>Dock score</td><td>-PLP1</td><td>-PLP2</td><td>-PMF</td></tr><tr><td>Tryptophan</td><td>171.283</td><td>27.71</td><td>27.51</td><td>23.06</td></tr><tr><td>Diiodotyrosine</td><td>171.000</td><td>20.22</td><td>20.27</td><td>23.51</td></tr><tr><td>Saussureamine C</td><td>170.814</td><td>27.27</...
<table><tr><td>Name</td><td>Dock score</td><td>-PLP1</td><td>-PLP2</td><td>-PMF</td></tr><tr><td>Tryptophan</td><td>171.283</td><td>27.71</td><td>27.51</td><td>23.06</td></tr><tr><td>Diiodotyrosine</td><td>171.000</td><td>20.22</td><td>20.27</td><td>23.51</td></tr><tr><td>Saussureamine C</td><td>170.814</td><td>27.27</...
<table><tr><td>Name</td><td>Dock score</td><td>-PLP1</td><td>-PLP2</td><td>-PMF</td></tr><tr><td>Tryptophan</td><td>169.656</td><td>36.05</td><td>32.98</td><td>21.91</td></tr><tr><td>Diiodotyrosine</td><td>168.307</td><td>33.24</td><td>27.04</td><td>16.58</td></tr><tr><td>5-Hydroxy-L-tryptophan</td><td>166.948</td><td>...
3a3848f24c6f94764b27927ebf3d3c57b472d704195270ef4d449b3694cad59e.png
simple
<table><tr><td>Query</td><td>Parameters inquired</td><td>Fluorescent wavelengths</td></tr><tr><td>1</td><td>FS, SS</td><td>2, 3 or 4</td></tr><tr><td>2</td><td>FS, SS, CD5</td><td>2, 3 or 4</td></tr><tr><td>3</td><td>FS, SS, CD5, CD20</td><td>2, 3 or 4</td></tr><tr><td>4</td><td>FS, SS, CD5, CD20, CD19, CD34</td><td>4<...
<table><tr><td>Query</td><td>Parameters inquired</td><td>Fluorescent wavelengths</td></tr></table>
<table><tr><td>1</td><td>FS, SS</td><td>2, 3 or 4</td></tr><tr><td>2</td><td>FS, SS, CD5</td><td>2, 3 or 4</td></tr><tr><td>3</td><td>FS, SS, CD5, CD20</td><td>2, 3 or 4</td></tr><tr><td>4</td><td>FS, SS, CD5, CD20, CD19, CD34</td><td>4</td></tr></table>
2d5cf23de93d6503fbc51321c208517c776fd77c89566fa14ae6aa4815242728.png
complex
<table><tr><td> </td><td colspan="3">LOS (days)</td><td colspan="3">Av. daily weight gain (gr)</td></tr><tr><td> </td><td>&#946;</td><td>95% C.I.</td><td>Pr(&gt;|t|)</td><td>&#946;</td><td>95% C.I.</td><td>Pr(&gt;|t|)</td></tr><tr><td>Male</td><td>-1.899</td><td>-3.930 , 0.127</td><td>0.07</td><td>0.708</td><td>-3.067 ...
<table><tr><td></td><td colspan="3">LOS (days)</td><td colspan="3">Av. daily weight gain (gr)</td></tr><tr><td></td><td>β</td><td>95% C.I.</td><td>Pr(>|t|)</td><td>β</td><td>95% C.I.</td><td>Pr(>|t|)</td></tr></table>
<table><tr><td>Male</td><td>-1.899</td><td>-3.930 , 0.127</td><td>0.07</td><td>0.708</td><td>-3.067 , 4.483</td><td>0.71</td></tr><tr><td>Gestational Age</td><td>-3.373</td><td>-3.916 , 2.830</td><td><0.001</td><td>-0.338</td><td>-1.344 , 0.668</td><td>0.51</td></tr><tr><td>Birth Weight (gr)</td><td>-0.014</td><td>-0.0...
9afb1ecd16b603f15af9272cfa580e81c52a041a3053576c122b6c220b174bde.png
complex
<table><tr><td>Housing arrangements</td><td colspan="9">No. of chickens (score <sup>a</sup>, liver/body weight ratio <sup>b</sup>)</td></tr><tr><td>Cage-free (Inoculated)</td><td>1(1, 23.16)</td><td>2(4, 40.92)</td><td>3(2, 23.44)</td><td>4(2, 32.19)</td><td>5(4, 37.98)</td><td>6(3, 33.25)</td><td>7(2, 24.01)</td><td>8...
<table><tr><td>Housing arrangements</td><td colspan="9">No. of chickens (score a, liver/body weight ratio b)</td></tr><tr><td>Cage-free (Inoculated)</td><td>1(1, 23.16)</td><td>2(4, 40.92)</td><td>3(2, 23.44)</td><td>4(2, 32.19)</td><td>5(4, 37.98)</td><td>6(3, 33.25)</td><td>7(2, 24.01)</td><td>8(4, 36.78)</td><td>9(2...
<table><tr><td>Housing arrangements</td><td colspan="9">No. of chickens (score a, liver/body weight ratio b)</td></tr><tr><td>Caged (Inoculated)</td><td>10(0, 24.84)</td><td>11(4, 36.47)</td><td>12(1, 23.39)</td><td>13(0, 22.08)</td><td>14(4, 35.88)</td><td>15(0, 24.12)</td><td>16(2, 23.98)</td><td>17 (1, 22.68)</td><t...
6ab952e6205dbdf1406bcf7d9f25a383f0ce583b6ee34c0f37ef309c5103a388.png
simple
<table><tr><td>AKI progression</td><td>Number of patients</td><td>ICU mortality</td><td>p</td></tr><tr><td>AKI I (n = 4259)</td><td></td><td></td><td></td></tr><tr><td>with rising creatinine values</td><td>1995 (46.8%)</td><td>522 (26.2%)</td><td>&lt; 0.0001</td></tr><tr><td>with falling creatinine values</td><td>2264 ...
<table><tr><td>AKI progression</td><td>Number of patients</td><td>ICU mortality</td><td>p</td></tr><tr><td>AKI I (n = 4259)</td><td></td><td></td><td></td></tr><tr><td>with rising creatinine values</td><td>1995 (46.8%)</td><td>522 (26.2%)</td><td>< 0.0001</td></tr><tr><td>with falling creatinine values</td><td>2264 (53...
<table><tr><td>AKI III without prior AKI I/AKI II</td><td>1118 (40.2%)</td><td>583 (46.2%)</td></tr></table>
5b10e2ceaff89ac66a79acc241b7c801e6261fead6355294864219f96024f0cc.png
simple
<table><tr><td></td><td><i>d</i> [g cm<sup>&#8722;3</sup>]</td><td>Porosity [&#966;]</td><td>&#961;<sub>323 K</sub> [m&#937; cm]</td><td><i>S</i><sub>323 K</sub> [&#956;V K<sup>&#8722;1</sup>]</td><td>&#954;<sub>L,773 K</sub> [W m<sup>&#8722;1</sup> K<sup>&#8722;1</sup>]</td></tr><tr><td>OM</td><td>7.1</td><td>14.1%</t...
<table><tr><td></td><td>d [g cm−3]</td><td>Porosity [φ]</td><td>ρ323 K [mΩ cm]</td><td>S323 K [μV K−1]</td><td>κL,773 K [W m−1 K−1]</td></tr><tr><td>OM</td><td>7.1</td><td>14.1%</td><td>1.12</td><td>−100</td><td>0.6</td></tr></table>
<table><tr><td>RM</td><td>7.9</td><td>4.5%</td><td>0.63</td><td>−88</td><td>0.7</td></tr></table>
11d5839599ce4fb9f610e53c60159449aeb15fba76e66079eebf1bed33c0f583.png
simple
<table><tr><td></td><td>PMO (<i>n</i> = 149)</td><td>CON (<i>n</i> = 172)</td><td><i>p-</i>Value</td></tr><tr><td>Age, years</td><td>61.4 (6.5)<sup>a</sup></td><td>57.5 (7.3)<sup>a</sup></td><td>&gt;0.05</td></tr><tr><td>Height, cm</td><td>159.2 (8.3)<sup>a</sup></td><td>165.1 (5.8)<sup>a</sup></td><td>&gt;0.05</td></t...
<table><tr><td></td><td>PMO (n = 149)</td><td>CON (n = 172)</td><td>p-Value</td></tr></table>
<table><tr><td>Age, years</td><td>61.4 (6.5)a</td><td>57.5 (7.3)a</td><td>>0.05</td></tr><tr><td>Height, cm</td><td>159.2 (8.3)a</td><td>165.1 (5.8)a</td><td>>0.05</td></tr><tr><td>Weight, kg</td><td>64.5 (7.2)a</td><td>73.3 (5.1)a</td><td>>0.05</td></tr><tr><td>Body mass index, kg/m2</td><td>26.7 (3.2)a</td><td>27.3 (...
e17c2bc47ea52ad47437262db834e804384089f87c830a60ca97b6be86cb494e.png
simple
<table><tr><td></td><td>Comm</td><td>Accom</td><td>Isol</td><td>NWI-NPRS</td><td>TeamVal</td><td>TeamEff</td><td>SharedLdr</td></tr><tr><td>Comm</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Accom</td><td>0.81</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Isol<...
<table><tr><td></td><td>Comm</td><td>Accom</td><td>Isol</td><td>NWI-NPRS</td><td>TeamVal</td><td>TeamEff</td></tr><tr><td>Comm</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Accom</td><td>0.81</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Isol</td><td>0.84</td><td>0.75</td><td></...
<table><tr><td>SharedLdr</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr></table>
835608484037771220d9bf8af1b64e38489e21ab08df47cc8faebd91f3c13e37.png
complex
<table><tr><td>Yes (+)</td><td>LBP+</td><td>LBP+</td><td>LBP&#8722;</td><td>LBP&#8722;</td><td rowspan="2">Missing answers on pain </td><td>LBP</td><td>SP </td><td>LBP </td><td>SP </td></tr><tr><td>No (&#8722;)</td><td>SP+</td><td>SP&#8722;</td><td>SP+</td><td>SP&#8722;</td><td>PIW+</td><td>PIW+</td><td>PINT+</td><td>P...
<table><tr><td>Ye</td><td>LB</td><td>LBP</td><td>LBP</td><td>L</td><td>Mis</td><td>LB</td><td>SP</td><td>L</td><td></td></tr></table>
<table><tr><td>s (+)</td><td>P+</td><td>+</td><td>−</td><td>BP−</td><td rowspan="2">sing answers on pain</td><td>P</td><td></td><td>BP</td><td>SP</td></tr><tr><td>No (−)</td><td>SP+</td><td>SP−</td><td>SP+</td><td>SP−</td><td>PIW+</td><td>PIW+</td><td>PINT+</td><td>PINT+</td></tr><tr><td>Number of workers n (%)</td><td...
2992304a2d539cfb6f9449e9bc4aec6f4691d989e710a7106556df16378ef113.png
simple
<table><tr><td>Lactate</td><td>&lt;2 mmol/L (n = 138)</td><td>&#8805;6 mmol/L (n = 29)</td><td><i>P </i>value</td></tr><tr><td>Major resection (%)</td><td>26 (18.8)</td><td>26 (89.7)</td><td>&lt;0.001*</td></tr><tr><td>Pre-operative chemotherapy (%)</td><td>38 (27.5)</td><td>5 (17.2)</td><td>0.351</td></tr><tr><td>Pre-...
<table><tr><td>Lactate</td><td><2 mmol/L (n = 138)</td><td>≥6 mmol/L (n = 29)</td><td>P value</td></tr><tr><td>Major resection (%)</td><td>26 (18.8)</td><td>26 (89.7)</td><td><0.001*</td></tr></table>
<table><tr><td>Pre-operative chemotherapy (%)</td><td>38 (27.5)</td><td>5 (17.2)</td><td>0.351</td></tr><tr><td>Pre-operative diabetes (%)</td><td>6 (4.3)</td><td>8 (27.6)</td><td><0.001*</td></tr><tr><td>Post-operative renal dysfunction (%)</td><td>3 (2.2)</td><td>8 (27.6)</td><td><0.001*</td></tr><tr><td>90-day morta...
f115f7a132b5eb44903a7dc3cb1cfcac1a777b09271c7d57040b641e21bf3093.png
complex
<table><tr><td></td><td colspan="2">Profile Width</td><td colspan="2">Neff</td></tr><tr><td>Superfamily</td><td>Full</td><td>Trimmed</td><td>Full</td><td>Trimmed</td></tr><tr><td>(Trans)glycosidases</td><td>410.4</td><td>23.93</td><td>13.11</td><td>3.21</td></tr><tr><td>4-helical cytokines</td><td>85.71</td><td>43.57</...
<table><tr><td></td><td colspan="2">Profile Width</td><td colspan="2">Neff</td></tr><tr><td>Superfamily</td><td>Full</td><td>Trimmed</td><td>Full</td><td>Trimmed</td></tr><tr><td>(Trans)glycosidases</td><td>410.4</td><td>23.93</td><td>13.11</td><td>3.21</td></tr><tr><td>4-helical cytokines</td><td>85.71</td><td>43.57</...
<table><tr><td>g</td><td>52</td><td>20.57</td><td>.33</td><td>3.68</td></tr><tr><td>Fibronectin type</td><td>1661.67</td><td>24.83</td><td>11.44</td><td>3.55</td></tr><tr><td>Homeodomain-like</td><td>255.21</td><td>39.33</td><td>7</td><td>3.34</td></tr><tr><td>Immunoglobulin</td><td>1614.7</td><td>69.04</td><td>11.33</...
4455ce6d91bfbe35e74be1e38cfcd772da801789a0718027fe27fd079f690559.png
complex
<table><tr><td rowspan="2">Zones</td><td colspan="5">Most Used Pesticides (Top 5) in %</td><td rowspan="2">Cumulative %</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td></tr><tr><td>Obala</td><td>Ridomil (8%)</td><td>Onex (6.3%)</td><td>Actara (5.7%)</td><td>Callomil (5%)</td><td>Lamida Gold, Parastar and...
<table><tr><td rowspan="2">Zones</td><td colspan="5">Most Used Pesticides (Top 5) in %</td><td rowspan="2">Cumulative %</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td></tr><tr><td>Obala</td><td>Ridomil (8%)</td><td>Onex (6.3%)</td><td>Actara (5.7%)</td><td>Callomil (5%)</td><td>Lamida Gold, Parastar and...
<table><tr><td rowspan="2">Zones</td><td colspan="5">Most Used Pesticides (Top 5) in %</td><td rowspan="2">Cumulative %</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td></tr><tr><td>Santa</td><td>Gramoxone (12.7%)</td><td>Banko (12%)</td><td>Pencozeb (8%)</td><td>Roundup and Mancozan (6.7% each)</td><td>P...
f7afcb0bfa194bdf47c4d21a20bc951c943a7fff34e9893ed60c999c752b71ba.png
simple
<table><tr><td>F0</td><td>F1</td><td>F2</td><td>F3</td></tr><tr><td>Hip center speed (m/s)</td><td>Shoulder center speed (m/s)</td><td>Right hip speed (&#952;/s) Frontal plane</td><td>Right hip angle (&#952;) Frontal plane</td></tr></table>
<table><tr><td>F0</td><td>F1</td><td>F2</td><td>F3</td></tr></table>
<table><tr><td>Hip center speed (m/s)</td><td>Shoulder center speed (m/s)</td><td>Right hip speed (θ/s) Frontal plane</td><td>Right hip angle (θ) Frontal plane</td></tr></table>
8682b566a062d7e57184960f0b2fba7859d61c1a0c1b34ca941f41d3b746c4a1.png
complex
<table><tr><td rowspan="2">Item</td><td colspan="4">Item clearly stated</td><td colspan="4">Agreement with item</td></tr><tr><td>Total n</td><td>Strongly agree</td><td>Somewhat agree</td><td>Combined agreement</td><td>Total n</td><td>Strongly agree</td><td>Somewhat agree</td><td>Combined agreement</td></tr><tr><td>Figu...
<table><tr><td rowspan="2">Item</td><td colspan="4">Item clearly stated</td><td colspan="4">Agreement with item</td></tr><tr><td>Total n</td><td>Strongly agree</td><td>Somewhat agree</td><td>Combined agreement</td><td>Total n</td><td>Strongly agree</td><td>Somewhat agree</td><td>Combined agreement</td></tr><tr><td>Figu...
<table><tr><td colspan="9">Lying</td></tr><tr><td>Definition</td><td>85</td><td>75 (88%)</td><td>6 (7%)</td><td>81 (95%)</td><td>85</td><td>75 (88%)</td><td>6 (7%)</td><td>81 (95%)</td></tr><tr><td>Caveats</td><td>84</td><td>76 (90%)</td><td>3 (4%)</td><td>79 (94%)</td><td>85</td><td>76 (89%)</td><td>4 (5%)</td><td>80 ...
18768233d1a13cd8d0d58f550d7caf4e012912e843b6ee0bb2ab782559263365.png
simple
<table><tr><td>Variables</td><td>GLM resultsinteraction effect<sup>a</sup></td><td>Statistical changes over time(p value)</td><td>Adjusted mean differences between groups over time<sup>b</sup>(Clinical changes)</td></tr><tr><td></td><td>Group * Time</td><td>T1 &#8594; T2</td><td>T1 &#8594; T2</td></tr><tr><td>EORTCQLQ-...
<table><tr><td>Variables</td><td>GLM resultsinteraction effecta</td><td>Statistical changes over time(p value)</td><td>Adjusted mean differences between groups over timeb(Clinical changes)</td></tr><tr><td></td><td>Group * Time</td><td>T1 → T2</td><td>T1 → T2</td></tr><tr><td>EORTCQLQ-C30:</td><td></td><td></td><td></t...
<table><tr><td>Insomnia</td><td>1.7</td><td>.184</td><td>+4.0</td></tr><tr><td>Appetite loss</td><td>0.1</td><td>.707</td><td>- 1.0</td></tr><tr><td>Constipation</td><td>8.6</td><td>.004</td><td>+7.5</td></tr><tr><td>Diarrhea</td><td>0.4</td><td>.545</td><td>- 1.1</td></tr><tr><td>Financial difficulties</td><td>51.7</t...
836b805b12d3dd56adf7619205ead6beb1cf789c1fe72d604642c7344bc83886.png
simple
<table><tr><td>Days in EB formation</td><td>Post EB differentiation</td><td>Differentiation conditions</td><td>Chondrogenic markers studied</td><td>Cells line(s)</td><td>Reference</td></tr><tr><td>5</td><td>Encapsulation of EBs in PEG hydrogel for 17 days</td><td>The EBs in hydrogel were differentiated in presence of c...
<table><tr><td>Days in EB formation</td><td>Post EB differentiation</td><td>Differentiation conditions</td><td>Chondrogenic markers studied</td><td>Cells line(s)</td><td>Reference</td></tr><tr><td>5</td><td>Encapsulation of EBs in PEG hydrogel for 17 days</td><td>The EBs in hydrogel were differentiated in presence of c...
<table><tr><td>Days in EB formation</td><td>Post EB differentiation</td><td>Differentiation conditions</td><td>Chondrogenic markers studied</td><td>Cells line(s)</td><td>Reference</td></tr><tr><td>N/R</td><td>EB cells were seeded on ceramic particles</td><td>Cells on the ceramic scaffold was differentiated in vitro for...
a58452d215753a0bf5b65996dfe89a299944bb3c1070cf33552854e0b658b7f2.png
simple
<table><tr><td></td><td>Anteparturm hemorrhage</td><td>Transverse lie</td><td>Placenta previa</td><td>Breech presentation</td><td>Ectopic pregnancy</td><td>Twins</td><td>Poly /oligo hydromnious</td></tr><tr><td>Very confident</td><td>23.3</td><td>13.3</td><td>10</td><td>13.3</td><td>3.3</td><td>13.3</td><td>0</td></tr>...
<table><tr><td></td><td>Anteparturm hemorrhage</td><td>Transverse lie</td><td>Placenta previa</td><td>Breech presentation</td><td>Ectopic pregnancy</td><td>Twins</td><td>Poly /oligo hydromnious</td></tr><tr><td>Very confident</td><td>23.3</td><td>13.3</td><td>10</td><td>13.3</td><td>3.3</td><td>13.3</td><td>0</td></tr>...
<table><tr><td></td><td>Anteparturm hemorrhage</td><td>Transverse lie</td><td>Placenta previa</td><td>Breech presentation</td><td>Ectopic pregnancy</td><td>Twins</td><td>Poly /oligo hydromnious</td></tr><tr><td>dent</td><td>0</td><td>0</td><td>.3</td><td>.7</td><td>7</td><td>60</td><td>33.3</td></tr><tr><td>Not confide...
1d888557e42660c3da9e6637065bdf5595243b1c4aaefbd5b380c9e0b351edfd.png
complex
<table><tr><td>EEG indices</td><td>Site</td><td>Before inhalation (<i>&#956;</i>V<sup>2</sup>)</td><td>During inhalation (<i>&#956;</i>V<sup>2</sup>)</td><td><i>t</i>-test</td><td><i>P</i>value<sup><i>&#8727;</i></sup></td></tr><tr><td colspan="6"><i>Both nostrils</i></td></tr><tr><td rowspan="2">RA</td><td>T3: left te...
<table><tr><td>EEG indices</td><td>Site</td><td>Before inhalation (μV2)</td><td>During inhalation (μV2)</td><td>t-test</td></tr><tr><td colspan="5">Both nostrils</td></tr><tr><td rowspan="2">RA</td><td>T3: left temporal</td><td>0.4271 ± 0.066</td><td>0.5103 ± 0.070</td><td>−2.593</td></tr><tr><td>T4: right temporal</td...
<table><tr><td>Pvalue∗</td></tr><tr><td>Both nostrils</td></tr><tr><td>0.029</td></tr><tr><td>0.036</td></tr><tr><td>0.040</td></tr><tr><td>Left nostril</td></tr><tr><td>0.009</td></tr><tr><td>0.004</td></tr><tr><td>0.020</td></tr><tr><td>0.40</td></tr><tr><td>Right nostril</td></tr><tr><td>0.045</td></tr><tr><td>0.032...
99c30fa0f5109037460fda13b2340932ace561524401db308cd7fa4f5e474cea.png
simple
<table><tr><td>Bacterial strain</td><td>Source</td><td>Reference</td></tr><tr><td><i>L. sakei </i>23K</td><td>Sausage</td><td>[66,67]</td></tr><tr><td><i>L. sakei </i>MF1053</td><td>Fermented fish (Norwegian "Rakfisk")</td><td>[30]</td></tr><tr><td><i>L. sakei </i>LS 25</td><td>Commercial starter culture for salami sau...
<table><tr><td>Bacterial strain</td><td>Source</td><td>Reference</td></tr></table>
<table><tr><td>L. sakei 23K</td><td>Sausage</td><td>[66,67]</td></tr><tr><td>L. sakei MF1053</td><td>Fermented fish (Norwegian "Rakfisk")</td><td>[30]</td></tr><tr><td>L. sakei LS 25</td><td>Commercial starter culture for salami sausage</td><td>[68]</td></tr><tr><td>L. sakei Lb790x</td><td>Meat</td><td>[69]</td></tr><t...
aa1d8db243dc680ab7bbfe8632c0d9f31d8f8f52ccd459908f7bbfea30d75c9f.png
complex
<table><tr><td rowspan="3"></td><td colspan="9">Sex</td></tr><tr><td colspan="3">T</td><td colspan="3">M</td><td colspan="3">F</td></tr><tr><td>N</td><td>Mean difference &#177; SD(mm)</td><td>P</td><td>N</td><td>Mean &#177; SD</td><td>P</td><td>N</td><td>Mean &#177; SD</td><td>P</td></tr><tr><td>UCPM</td><td rowspan="2...
<table><tr><td rowspan="3"></td><td colspan="9">Sex</td></tr><tr><td colspan="3">T</td><td colspan="3">M</td><td colspan="3">F</td></tr><tr><td>N</td><td>Mean difference ± SD(mm)</td><td>P</td><td>N</td><td>Mean ± SD</td><td>P</td><td>N</td><td>Mean ± SD</td><td>P</td></tr></table>
<table><tr><td>UCPM</td><td rowspan="2">359</td><td>−0.41 ± 0.88</td><td>***</td><td rowspan="2">169</td><td>−0.21 ± 0.88</td><td>**</td><td rowspan="2">190</td><td>−0.59 ± 0.85</td><td>***</td></tr><tr><td>LCPM</td><td>−0.42 ± 0.91</td><td>***</td><td>−0.20 ± 0.91</td><td>**</td><td>−0.61 ± 0.86</td><td>***</td></tr><...
4518b05fa9fe03a2450c7f5ae8108ee9e67b4a1d82406fc0d48ac3675f66bd26.png
complex
<table><tr><td rowspan="2">Ligands</td><td colspan="2">XPGScore</td><td rowspan="2">Winning score</td><td rowspan="2">CDM</td></tr><tr><td>2XYT-based &#945;7 nAChR-LBD</td><td>3SQ6-based &#945;7 nAChR-LBD</td></tr><tr><td>Acetylcholine</td><td>&#8722;4.68</td><td>&#8722;4.812</td><td>&#8722;4.812</td><td>0.132</td></tr...
<table><tr><td rowspan="2">Ligands</td><td colspan="2">XPGScore</td><td rowspan="2">Winning score</td><td rowspan="2">CDM</td></tr><tr><td>2XYT-based α7 nAChR-LBD</td><td>3SQ6-based α7 nAChR-LBD</td></tr><tr><td>Acetylcholine</td><td>−4.68</td><td>−4.812</td><td>−4.812</td><td>0.132</td></tr><tr><td>epibatidine</td><td...
<table><tr><td rowspan="2">Ligands</td><td colspan="2">XPGScore</td><td rowspan="2">Winning score</td><td rowspan="2">CDM</td></tr><tr><td>2XYT-based α7 nAChR-LBD</td><td>3SQ6-based α7 nAChR-LBD</td></tr><tr><td>NS1738</td><td>−7.108</td><td>−8.513</td><td>−8.513</td><td>0.953</td></tr><tr><td>PNU120596</td><td>−4.992<...
a9678fd4845a4cf0301163e5521c7117d9fd196e25c0a810145d7b1b9f39fd58.png
simple
<table><tr><td>Predictors</td><td><i>B</i></td><td>SE <i>B</i></td><td>&#946;</td><td><i>t</i></td><td><i>p</i></td></tr><tr><td>Preference</td><td>0.21</td><td>0.05</td><td>0.13</td><td>3.79</td><td>&lt;.0001</td></tr><tr><td>Originality</td><td>0.58</td><td>0.08</td><td>0.47</td><td>7.17</td><td>&lt;.0001</td></tr><t...
<table><tr><td>Predictors</td><td>B</td></tr><tr><td>Preference</td><td>0.21</td></tr><tr><td>Originality</td><td>0.58</td></tr><tr><td>Ambiguity</td><td>0.32</td></tr><tr><td>Understanding</td><td>− 0.39</td></tr></table>
<table><tr><td>SE B</td><td>β</td><td>t</td><td>p</td></tr><tr><td>0.05</td><td>0.13</td><td>3.79</td><td><.0001</td></tr><tr><td>0.08</td><td>0.47</td><td>7.17</td><td><.0001</td></tr><tr><td>0.06</td><td>0.29</td><td>5.05</td><td><.0001</td></tr><tr><td>0.02</td><td>− 0.34</td><td>− 14.05</td><td><.0001</td></tr></ta...
abcd28a357aae78a89c54542303b9fd5b3dab6ff47a04db57a88a7f071dc4d3f.png
simple
<table><tr><td>Methylated bases in 100 bp</td><td><i>SCREAM2</i></td><td><i>FAMAa</i></td><td><i>FAMAb</i></td><td><i>SPCHa</i></td><td><i>SPCHb</i></td></tr><tr><td>LRH (Parent)</td><td>0</td><td>17</td><td>14</td><td>0</td><td>30.2</td></tr><tr><td>LRH-control</td><td>0.1</td><td>13.5</td><td>12.9</td><td>0</td><td>2...
<table><tr><td>Methylated bases in 100 bp</td><td>SCREAM2</td><td>FAMAa</td><td>FAMAb</td><td>SPCHa</td><td>SPCHb</td></tr><tr><td>LRH (Parent)</td><td>0</td><td>17</td><td>14</td><td>0</td><td>30.2</td></tr><tr><td>LRH-control</td><td>0.1</td><td>13.5</td><td>12.9</td><td>0</td><td>29.2</td></tr><tr><td>Entropy (Hχ)</...
<table><tr><td>Methylated bases in 100 bp</td><td>SCREAM2</td><td>FAMAa</td><td>FAMAb</td><td>SPCHa</td><td>SPCHb</td></tr><tr><td>ntropy (Hχ)</td><td></td><td>.08</td><td>7</td><td>0.015</td><td></td></tr><tr><td>χ2 treatment</td><td>ns</td><td><0.001</td><td><0.001</td><td>ns</td><td><0.001</td></tr><tr><td>χ2 inheri...
5504607b9433071ba4f94cbba2637337309ee0f6e117c57997f018e8ee64652e.png
simple
<table><tr><td>ESTs per unigene</td><td><i>H. erato</i></td><td><i>H. melpomene</i></td></tr><tr><td>1 (singletons)</td><td>319</td><td>256</td></tr><tr><td>2</td><td>13</td><td>31</td></tr><tr><td>3</td><td>5</td><td>12</td></tr><tr><td>4</td><td>9</td><td>10</td></tr><tr><td>5&#8211;10</td><td>14</td><td>17</td></tr>...
<table><tr><td>ESTs per unigene</td><td>H. erato</td><td>H. melpomene</td></tr><tr><td>1 (singletons)</td><td>319</td><td>256</td></tr><tr><td>2</td><td>13</td><td>31</td></tr><tr><td></td><td></td><td></td></tr></table>
<table><tr><td>ESTs per unigene</td><td>H. erato</td><td>H. melpomene</td></tr><tr><td>3</td><td>5</td><td>12</td></tr><tr><td>4</td><td>9</td><td>10</td></tr><tr><td>5–10</td><td>14</td><td>17</td></tr><tr><td>11–20</td><td>7</td><td>9</td></tr><tr><td>21–50</td><td>3</td><td>3</td></tr><tr><td>>51</td><td>1</td><td>2...
893eee127fcbabf69bcd80e179c467fd3254de00b34d2d36a9acea1758cf24bb.png
simple
<table><tr><td>Gene </td><td>Sequence</td><td>bp </td></tr><tr><td>Beclin-1</td><td>Sense 5&#8242; CCAGATGCGTTATGCCCAGAC 3&#8242; Anti-sense 5&#8242; CATTCCATTCCACGGGAACAC 3&#8242;</td><td>149</td></tr><tr><td>mTOR</td><td>Sense 5&#8242; AAACTGCACGTCAGCACCATC 3&#8242; Anti-sense 5&#8242; AGCCGTCTCAGCCATTCCA 3&#8242;</t...
<table><tr><td>Gene</td><td>Sequence</td><td>bp</td></tr></table>
<table><tr><td>Beclin-1</td><td>Sense 5′ CCAGATGCGTTATGCCCAGAC 3′ Anti-sense 5′ CATTCCATTCCACGGGAACAC 3′</td><td>149</td></tr><tr><td>mTOR</td><td>Sense 5′ AAACTGCACGTCAGCACCATC 3′ Anti-sense 5′ AGCCGTCTCAGCCATTCCA 3′</td><td>192</td></tr><tr><td>ATG5</td><td>Sense 5′CCATCAATCGGAAACTCATGGA 3′ Anti-sense 5′ATCTGCAGCCACA...
7fed621b34482151519ac282277cc5ff6f2235a5ea1be88d8ef27fab92788c21.png
simple
<table><tr><td></td><td>TIV</td><td>GM volume</td><td>WM volume</td><td>CSF volume</td></tr><tr><td>FIS total</td><td>&#8722; 0.3540.023</td><td>&#8722; 0.5870.011</td><td>0.3490.138</td><td>&#8722; 0.4200.015</td></tr><tr><td>FIS cognitive</td><td>&#8722; 0.3360.032</td><td>&#8722; 0.6630.004</td><td>0.399<i>0</i>.<i>...
<table><tr><td></td><td>TIV</td><td>GM volume</td><td>WM volume</td><td>CSF volume</td></tr><tr><td>FIS total</td><td>− 0.3540.023</td><td>− 0.5870.011</td><td>0.3490.138</td><td>− 0.4200.015</td></tr></table>
<table><tr><td></td><td>TIV</td><td>GM volume</td><td>WM volume</td><td>CSF volume</td></tr><tr><td>FIS cognitive</td><td>− 0.3360.032</td><td>− 0.6630.004</td><td>0.3990.089</td><td>− 0.3710.030</td></tr><tr><td>FIS physical</td><td>− 0.1740.276</td><td>− 0.3040.206</td><td>0.3040.226</td><td>− 0.3950.031</td></tr><tr...
38741eec998ad6c085000aac486bd3fb13b5f358770060bffcbd690b40a48bd6.png
complex
<table><tr><td></td><td>Education<sup>a</sup></td><td>Household income (LICO)<sup>b</sup></td><td>Neihgbourhood SEP<sup>c</sup></td><td>Combined SEP<sup>d</sup></td></tr><tr><td colspan="5"><i>A- Maternal and infant health status indicators</i></td></tr><tr><td>1. Preterm Birth</td><td>+</td><td>NS</td><td>NS</td><td>+...
<table><tr><td></td><td>Educationa</td><td>Household income (LICO)b</td><td>Neihgbourhood SEPc</td><td>Combined SEPd</td></tr><tr><td colspan="5">A- Maternal and infant health status indicators</td></tr><tr><td>1. Preterm Birth</td><td>+</td><td>NS</td><td>NS</td><td>+ (*) (low-high)</td></tr><tr><td>2. Small for gesta...
<table><tr><td></td><td>Educationa</td><td>Household income (LICO)b</td><td>Neihgbourhood SEPc</td><td>Combined SEPd</td></tr><tr><td>16. Position for vaginal birth (not laying flat)</td><td>NS</td><td>+</td><td>+</td><td>+ (low-low)</td></tr><tr><td colspan="5">D- Medical care during the neonatal period</td></tr><tr><...
a7145f591a43a1d3afce9d780e7b0d13afd531a885328abe102a554ad26f157d.png
simple
<table><tr><td>Demographic Variables</td><td>Number</td></tr><tr><td>Ages</td><td></td></tr><tr><td>15-19</td><td>2</td></tr><tr><td>20-24</td><td>2</td></tr><tr><td>25-29</td><td>2</td></tr><tr><td>30-34</td><td>1</td></tr><tr><td>35-39</td><td>2</td></tr><tr><td>40-44</td><td>1</td></tr><tr><td>45-49</td><td>0</td></...
<table><tr><td>Demographic Variables</td><td>Number</td></tr><tr><td>Ages</td><td></td></tr><tr><td>15-19</td><td>2</td></tr><tr><td>20-24</td><td>2</td></tr><tr><td>25-29</td><td>2</td></tr><tr><td>30-34</td><td>1</td></tr><tr><td>35-39</td><td>2</td></tr><tr><td>40-44</td><td>1</td></tr><tr><td>45-49</td><td>0</td></...
<table><tr><td>Demographic Variables</td><td>Number</td></tr><tr><td>04-Mar</td><td>6</td></tr><tr><td>5+</td><td>2</td></tr><tr><td>Total</td><td>10</td></tr><tr><td>Employment Status</td><td></td></tr><tr><td>Unemployed</td><td>7</td></tr><tr><td>Employed</td><td>2</td></tr><tr><td>Other: e.g. self-employed as petty ...
a99a06632fd0e85cd6915e2cd31769a611a9d1cfab6bab49ec3bbfd09698264a.png
complex
<table><tr><td><i>C</i><sub>i</sub>(phenol), mg&#183;L<sup>&#8722;1</sup></td><td>15</td><td>40</td><td>100</td><td>150</td><td>200</td><td>250</td><td>300</td></tr><tr><td colspan="8">MIP 3 (EGDMA)</td></tr><tr><td><i>Q</i>(MIP), mg&#183;g<sup>&#8722;</sup><sup>1</sup></td><td>2.60</td><td>6.30</td><td>13.0</td><td>17...
<table><tr><td>Ci(phenol), mg·L−1</td><td>15</td><td>40</td><td>100</td><td>150</td><td>200</td><td>250</td><td>300</td></tr><tr><td colspan="8">MIP 3 (EGDMA)</td></tr><tr><td>Q(MIP), mg·g−1</td><td>2.60</td><td>6.30</td><td>13.0</td><td>17.0</td><td>21.7</td><td>23.7</td><td>26.2</td></tr><tr><td>Q(NIP), mg·g−1</td><t...
<table><tr><td>Ci(phenol), mg·L−1</td><td>15</td><td>40</td><td>100</td><td>150</td><td>200</td><td>250</td><td>300</td></tr><tr><td></td><td>1.79</td><td>91</td><td>0.1</td><td>4.9</td><td>8.4</td><td>2.3</td><td>.1</td></tr><tr><td>Q(NIP), mg·g−1</td><td>1.72</td><td>4.76</td><td>9.7</td><td>14.2</td><td>17.4</td><td...
37725ddc93c7fce3fa2dc50e24fe8f5b192371f81c8ed53c4d32b544be1e2c51.png
simple
<table><tr><td>Group</td><td>Base</td><td>2 h</td><td>8 h</td><td>24 h</td><td>48 h</td></tr><tr><td>Ctrl</td><td>0 (0&#8211;0)</td><td>3 (3&#8211;4)</td><td>3 (3&#8211;4)</td><td>3 (2&#8211;4)</td><td>3 (2&#8211;3)</td></tr><tr><td>Z-VEID</td><td>0 (0&#8211;0)</td><td>3 (2&#8211;4)</td><td>3 (2&#8211;3)</td><td>2 (1&#...
<table><tr><td>Group</td><td>Base</td><td>2 h</td><td>8 h</td><td>24 h</td><td>48 h</td></tr><tr><td>Ctrl</td><td>0 (0–0)</td><td>3 (3–4)</td><td>3 (3–4)</td><td>3 (2–4)</td><td>3 (2–3)</td></tr><tr><td>Z-VEID</td><td>0 (0–0)</td><td>3 (2–4)</td><td>3 (2–3)</td><td>2 (1–3)</td><td>2 (1–2)a</td></tr><tr><td>Z-I</td><td>...
<table><tr><td>ETD</td><td>4)</td><td>3)</td><td>3)</td><td>1–2)a</td></tr></table>
b60bc0c37bd25cf6f8720df541bc26bf5cbb67343118af049861a3a57f54306e.png
complex
<table><tr><td>Ingredient</td><td colspan="2">Fish oil-based diet<sup>1</sup></td><td colspan="2">Saturated fat-based diet<sup>2</sup></td></tr><tr><td></td><td><i>g (%)</i></td><td><i>Kcal</i></td><td><i>g (%)</i></td><td><i>Kcal (%)</i></td></tr><tr><td>Protein</td><td>23.7</td><td>20</td><td>23.7</td><td>20</td></tr...
<table><tr><td>Ingredient</td><td colspan="2">Fish oil-based diet1</td><td colspan="2">Saturated fat-based diet2</td></tr><tr><td></td><td>g (%)</td><td>Kcal</td><td>g (%)</td><td>Kcal (%)</td></tr><tr><td>Protein</td><td>23.7</td><td>20</td><td>23.7</td><td>20</td></tr><tr><td>Carbohydrate</td><td>41.4</td><td>35</td>...
<table><tr><td>Ingredient</td><td colspan="2">Fish oil-based diet1</td><td colspan="2">Saturated fat-based diet2</td></tr><tr><td>Casein</td><td>200 (23.3)</td><td>800</td><td>200 (23.3)</td><td>800</td></tr><tr><td>L-Cystine</td><td>3 (0.35)</td><td>12</td><td>3 (0.35)</td><td>12</td></tr><tr><td>Corn starch</td><td>7...
946c2a3cf4817d9405e4c4d8ecfd323722259459ac5f5445dfb0c5a3a127f9e0.png
simple
<table><tr><td>Agent*</td><td>Time (s)</td><td>Capping efficiency</td></tr><tr><td>Acetic anhydride</td><td>15</td><td>60 &#177; 4%</td></tr><tr><td>Acetic anhydride</td><td>30</td><td>81 &#177; 2%</td></tr><tr><td>Acetic anhydride</td><td>60</td><td>92 &#177; 2%</td></tr><tr><td>Acetic anhydride</td><td>120</td><td>95...
<table><tr><td>Agent*</td><td>Time (s)</td><td>Capping efficiency</td></tr></table>
<table><tr><td>Acetic anhydride</td><td>15</td><td>60 ± 4%</td></tr><tr><td>Acetic anhydride</td><td>30</td><td>81 ± 2%</td></tr><tr><td>Acetic anhydride</td><td>60</td><td>92 ± 2%</td></tr><tr><td>Acetic anhydride</td><td>120</td><td>95 ± 2%</td></tr><tr><td>DMT-dT</td><td>15</td><td>91 ± 2%</td></tr><tr><td>DMT-dT</t...
70918a4d27bdd06d590fc74c117458d68e58653077a034f67c2bd095b57ddd94.png
complex
<table><tr><td></td><td></td><td>Abnormalcardiometabolic profile</td><td>Normalcardiometabolic profile</td><td>TOTAL</td></tr><tr><td>Untreated</td><td>"Normal" weight(BMI = 18.5 - 24.9)</td><td>23.5%(16.3 million people)<sup>b</sup></td><td>76.5%(53.0 million people)</td><td>100%(69.3 million people)</td></tr><tr><td>...
<table><tr><td></td><td></td><td>Abnormalcardiometabolic profile</td><td>Normalcardiometabolic profile</td><td>TOTAL</td></tr><tr><td>Untreated</td><td>"Normal" weight(BMI = 18.5 - 24.9)</td><td>23.5%(16.3 million people)b</td><td>76.5%(53.0 million people)</td><td>100%(69.3 million people)</td></tr><tr><td>Treated</td...
<table><tr><td></td><td>"Obese"(BMI ≥ 30.0)</td><td>68.3%(42.0 million people)</td><td>31.7%(19.5 million people)c</td><td>100%(61.5 million people)</td></tr><tr><td colspan="2">TOTAL</td><td>46%92.4 million people</td><td>54%108.4 million people</td><td>100%200.8 million people</td></tr></table>
c1f157bc02605c72f4b4c49df42418f56bd87ec263de20f44652525bd74ab85d.png
complex
<table><tr><td></td><td colspan="5">Number of controls</td></tr><tr><td></td><td>10</td><td>60</td><td>110</td><td>160</td><td>210</td></tr><tr><td>Percentage of results that included the mutation (%)</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td></tr><tr><td>Percentage of mutation loci in the top hit...
<table><tr><td></td><td colspan="5">Number of controls</td></tr><tr><td></td><td>10</td><td>60</td><td>110</td><td>160</td><td>210</td></tr><tr><td>Percentage of results that included the mutation (</td><td>10</td><td></td><td></td><td>100</td><td>10</td></tr></table>
<table><tr><td></td><td colspan="5">Number of controls</td></tr><tr><td></td><td>10</td><td>60</td><td>110</td><td>160</td><td>210</td></tr><tr><td>%)</td><td>0</td><td>100</td><td>100</td><td></td><td>0</td></tr><tr><td>Percentage of mutation loci in the top hit (%)</td><td>46</td><td>43</td><td>37</td><td>38</td><td>...
5031f4602d6fcf2b7690daf0cfcfaf8e88550436e0502256f94771f3247a8d40.png
simple
<table><tr><td>Cantilever ID</td><td><i>L</i> &#956;m</td><td>-Sphere -material</td><td>Sphere number</td><td>Sphere diameter, &#956;m</td><td>Resonance Frequency -kHz</td><td>&#916;Lm &#956;m</td></tr><tr><td>DNP 6A</td><td>108</td><td>Gold</td><td>&#8211;</td><td>0</td><td>62.8</td><td>&#8211;</td></tr><tr><td></td><...
<table><tr><td>Cantilever ID</td><td>L μm</td><td>-Sphere -material</td><td>Sphere number</td><td>Sphere diameter, μm</td><td>Resonance Frequency -kHz</td><td>ΔLm μm</td></tr><tr><td>DNP 6A</td><td>108</td><td>Gold</td><td>–</td><td>0</td><td>62.8</td><td>–</td></tr><tr><td></td><td></td><td>19300</td><td>1</td><td>3.8...
<table><tr><td>Cantilever ID</td><td>L μm</td><td>-Sphere -material</td><td>Sphere number</td><td>Sphere diameter, μm</td><td>Resonance Frequency -kHz</td><td>ΔLm μm</td></tr><tr><td></td><td></td><td></td><td>3</td><td>9.5</td><td>31.2</td><td>−1.1</td></tr><tr><td></td><td></td><td></td><td>–</td><td>0</td><td>62.8</...
015b85a7bf77b899abe494b8823b81202f915fd2af1eee4b5c57ee552932c88d.png
complex
<table><tr><td rowspan="2">Variable</td><td colspan="4">Before matching</td><td colspan="4">After matching</td></tr><tr><td>Atypical cohort N = 648</td><td>Typical cohort N = 483</td><td>p-value</td><td>Standardized difference</td><td>Atypical cohort N = 400</td><td>Typical cohort N = 400</td><td>p-value</td><td>Standa...
<table><tr><td rowspan="2">Variable</td></tr><tr></tr><tr><td>Demographic characteristics</td></tr><tr><td>Mean age (in years) [Mean(SD)]</td></tr><tr><td>Female [n(%)]</td></tr><tr><td>Retired [n(%)]</td></tr><tr><td>Concomitant medications [n(%)]</td></tr><tr><td>Anxiolytics</td></tr><tr><td>Anticholinergics</td></tr...
<table><tr><td colspan="4">Before matching</td><td colspan="4">After matching</td></tr><tr><td>Atypical cohort N = 648</td><td>Typical cohort N = 483</td><td>p-value</td><td>Standardized difference</td><td>Atypical cohort N = 400</td><td>Typical cohort N = 400</td><td>p-value</td><td>Standardized difference</td></tr><t...
e5a7942a44f624703e5e630307e740606a7e9f5e804d8554bd4dd34c63eec7c8.png
complex
<table><tr><td colspan="2">All Sounds &gt; Baseline</td></tr><tr><td>Region</td><td>Number of Voxels</td></tr><tr><td>Right Frontal Cortex</td><td>14335</td></tr><tr><td>Frontal pole</td><td></td></tr><tr><td>Frontal orbital cortex</td><td></td></tr><tr><td>Middle frontal gyrus</td><td></td></tr><tr><td>Pars operculari...
<table><tr><td colspan="2">All Sounds > Baseline</td></tr><tr><td>Region</td><td>Number of Voxels</td></tr><tr><td>Right Frontal Cortex</td><td>14335</td></tr><tr><td>Frontal pole</td><td></td></tr><tr><td>Frontal orbital cortex</td><td></td></tr><tr><td>Middle frontal gyrus</td><td></td></tr><tr><td>Pars op</td><td></...
<table><tr><td>ercularis</td><td></td></tr><tr><td>Pars triangularis</td><td></td></tr><tr><td>Right Temporal Cortex</td><td>2243</td></tr><tr><td>Middle temporal gyrus, posterior division and temporoccipital part</td><td></td></tr><tr><td>Superior temporal gyrus, posterior division</td><td></td></tr><tr><td>Heschl’s g...
1e28fa0ba7e3994a9e487ba5dadaf447dbcd9ec75ce06e547e471c0f692bb8c2.png
complex
<table><tr><td rowspan="2"></td><td>Total</td><td colspan="2">Recognise pregnancy warning signs<sup>b</sup></td><td colspan="2">Recognise pregnancy hypertension warning signs</td><td colspan="2">Recognise convulsions</td></tr><tr><td>N (%)</td><td>N (%)</td><td>OR (95 % CI)<sup>a</sup></td><td>N (%)</td><td>OR (95 % CI...
<table><tr><td rowspan="2"></td><td>Total</td><td colspan="2">Recognise pregnancy warning signsb</td><td colspan="2">Recognise pregnancy hypertension warning signs</td><td colspan="2">Recognise convulsions</td></tr><tr><td>N (%)</td><td>N (%)</td><td>OR (95 % CI)a</td><td>N (%)</td><td>OR (95 % CI)a</td><td>N (%)</td><...
<table><tr><td>ng</td><td>2 (14.8)</td><td>5.0)</td><td>(0.01 - 1.21)</td><td>4 (33.3)</td><td>5)</td><td>7)</td><td>4 (0.19 - 4.39)</td></tr><tr><td colspan="8">Years working as community health worker</td></tr><tr><td>Median (IQR)</td><td>2 (1–8)</td><td>-</td><td>1.19 (0.93 - 1.94)</td><td>-</td><td>1.04 (0.97 - 1.1...
1d24b2d6b6d32cfec2b74ef4a517a3c0cf1e5ff4b02467039ae1ce72206477b0.png
complex
<table><tr><td></td><td colspan="3">Any GI problem</td><td colspan="3">Constipation</td><td colspan="3">Reflux</td><td colspan="3">Air swallowing</td></tr><tr><td></td><td colspan="3">(<i>n</i> = 94)</td><td colspan="3">(<i>n</i> = 73)</td><td colspan="3">(<i>n</i> = 51)</td><td colspan="3">(<i>n</i> = 25)</td></tr><tr...
<table><tr><td></td><td colspan="3">Any GI problem</td><td colspan="3">Constipation</td><td colspan="3">Reflux</td><td colspan="3">Air swallowing</td></tr><tr><td></td><td colspan="3">(n = 94)</td><td colspan="3">(n = 73)</td><td colspan="3">(n = 51)</td><td colspan="3">(n = 25)</td></tr><tr><td></td><td>n (%)</td><td>...
<table><tr><td></td><td colspan="3">Any GI problem</td><td colspan="3">Constipation</td><td colspan="3">Reflux</td><td colspan="3">Air swallowing</td></tr><tr><td></td><td colspan="3">(n = 94)</td><td colspan="3">(n = 73)</td><td colspan="3">(n = 51)</td><td colspan="3">(n = 25)</td></tr><tr><td></td><td>n (%)</td><td>...
c5dfb62a25457b7853b5e28e2da6a91b811a2c7a45795dfeebdf09838cfbd3bf.png
complex
<table><tr><td rowspan="2" colspan="2"></td><td colspan="3">9-y-olds</td><td colspan="3">15-y-olds</td></tr><tr><td>MVPA (b (95% CI))</td><td><i>p</i></td><td><i>n</i></td><td>MVPA (b (95% CI))</td><td><i>p</i></td><td><i>n</i></td></tr><tr><td colspan="2">Sleep</td><td>0.3 (&#8722;1.5, 2.2)</td><td>0.740</td><td>2053<...
<table><tr><td rowspan="2" colspan="2"></td><td colspan="3">9-y-olds</td><td colspan="3">15-y-olds</td></tr><tr><td>MVPA (b (95% CI))</td><td>p</td><td>n</td><td>MVPA (b (95% CI))</td><td>p</td><td>n</td></tr><tr><td colspan="2">Sleep</td><td>0.3 (−1.5, 2.2)</td><td>0.740</td><td>2053</td><td>1.3 (− 1.0, 3.6)</td><td>0...
<table><tr><td rowspan="2" colspan="2"></td><td colspan="3">9-y-olds</td><td colspan="3">15-y-olds</td></tr><tr><td>MVPA (b (95% CI))</td><td>p</td><td>n</td><td>MVPA (b (95% CI))</td><td>p</td><td>n</td></tr><tr><td colspan="2">≤ 5 min/d</td><td>ref.</td><td></td><td>900</td><td>ref.</td><td></td><td>619</td></tr><tr>...
b7ad7daf435c20acbc27272ffdf82e15dae4b4a0602952754b9d1684451a8c66.png
simple
<table><tr><td>Cytology</td><td>Mean Age</td><td>No. of SpecimensN,(%)</td><td>Overall HPV (+)%</td></tr><tr><td>Normal</td><td>38.1 &#177; 9.4 (20-67)</td><td>310 (77%)</td><td>20%</td></tr><tr><td>Abnormal Cytology</td><td>35.6 &#177; 8.7(19-58)</td><td>93 (23%)</td><td>36%</td></tr><tr><td> ASCUS</td><td>37.0 &#177;...
<table><tr><td>Cytology</td><td>Mean Age</td><td>No. of SpecimensN,(%)</td><td>Overall HPV (+)%</td></tr><tr><td>Normal</td><td>38.1 ± 9.4 (20-67)</td><td>310 (77%)</td><td>20%</td></tr><tr><td>Abnormal Cytology</td><td>35.6 ± 8.7(19-58)</td><td>93 (23%)</td><td>36%</td></tr><tr><td>ASCUS</td><td>37.0 ± 8.8</td><td>39 ...
<table><tr><td>LSIL</td><td>33.6 ± 8.9</td><td>43 (46%)</td><td>51%</td></tr><tr><td>HSIL</td><td>38.0 ± 6.9</td><td>10 (11%)</td><td>60%</td></tr></table>
6dcd72a6e9b5ddf1773eb90f16193b8fadb4876533d18b4725477358ae5bf103.png
simple
<table><tr><td></td><td>General evidence</td><td>Managerial Accounting tools</td><td>HRM tools</td><td>ICT tools</td><td>Outcomes</td><td>Open issues</td></tr><tr><td>Progressive patient care model</td><td>In some contexts implementation by law (e.g. Tuscany)Great autonomy of organizations on how to implement modelForm...
<table><tr><td></td><td>General evidence</td><td>Managerial Accounting tools</td><td>HRM tools</td><td>ICT tools</td><td>Outcomes</td><td>Open issues</td></tr></table>
<table><tr><td>Progressive patient care model</td><td>In some contexts implementation by law (e.g. Tuscany)Great autonomy of organizations on how to implement modelForms of implementation:poles; separation elective/unscheduled/emergency patients; distinct inpatient/outpatient pathways; emphasis on ED; pool beds; centra...
adf91701d47b7245ebe6b64c0db09391c82116a89a6c707be2f2db2846313db2.png
complex
<table><tr><td colspan="7">Chroma C* at 8 &#176;C</td></tr><tr><td rowspan="2">Days</td><td colspan="3">Without HPP Treatment</td><td colspan="3">With HPP Treatment</td></tr><tr><td>Control</td><td>PF Film</td><td>PS Film</td><td>Control</td><td>PF Film</td><td>PS Film</td></tr><tr><td>0</td><td>26.99 <sup>A,a</sup> &#...
<table><tr><td colspan="7">Chroma C* at 8 °C</td></tr><tr><td rowspan="2">Days</td><td colspan="3">Without HPP Treatment</td><td colspan="3">With HPP Treatment</td></tr><tr><td>Control</td><td>PF Film</td><td>PS Film</td><td>Control</td><td>PF Film</td><td>PS Film</td></tr><tr><td>0</td><td>26.99 A,a ± 2.48</td><td>26....
<table><tr><td colspan="7">Chroma C* at 8 °C</td></tr><tr><td rowspan="2">Days</td><td colspan="3">Without HPP Treatment</td><td colspan="3">With HPP Treatment</td></tr><tr><td>Control</td><td>PF Film</td><td>PS Film</td><td>Control</td><td>PF Film</td><td>PS Film</td></tr><tr><td>12</td><td>24.95 A,a ± 0.15</td><td>26...
f2e0aeab191e719b67b8b39028c8adc1c598d5fcadc7b207c1d2c420b46dd215.png
complex
<table><tr><td>Unigene No.</td><td>Gene name</td><td>Copies</td><td>%*</td></tr><tr><td colspan="4">Fetal pituitary</td></tr><tr><td>Hs.1905</td><td>prolactin+#</td><td>312</td><td>9.46</td></tr><tr><td>Hs.119689</td><td>glycoprotein hormones, alpha +#</td><td>146</td><td>4.43</td></tr><tr><td>Hs.115352</td><td>growth ...
<table><tr><td>Unigene No.</td><td>Gene name</td><td>Copies</td><td>%*</td></tr><tr><td colspan="4">Fetal pituitary</td></tr><tr><td>Hs.1905</td><td>prolactin+#</td><td>312</td><td>9.46</td></tr><tr><td>Hs.119689</td><td>glycoprotein hormones, alpha +#</td><td>146</td><td>4.43</td></tr><tr><td>Hs.115352</td><td>growth ...
<table><tr><td>Unigene No.</td><td>Gene name</td><td>Copies</td><td>%*</td></tr><tr><td>Hs.112844</td><td>maternally expressed 3#</td><td>16</td><td>0.27</td></tr><tr><td>Hs.117950</td><td>phosphoribosylaminoimidazole carboxylase#</td><td>16</td><td>0.27</td></tr><tr><td>Hs.119598</td><td>ribosomal protein L3#</td><td>...
4790eb7044a56aa6742066ede6f95f463b30dae14f8d596ddaa2d0e09f0feb6d.png
simple
<table><tr><td>Variable</td><td>PFNA (<i>n</i> = 72)</td><td>DHS (<i>n</i> = 70)</td><td><i>P</i> value</td></tr><tr><td>Total complications</td><td>15</td><td>31</td><td>0.003</td></tr><tr><td> Patients affected</td><td>15 (20.8%)</td><td>31 (42.9%)</td><td>0.003</td></tr><tr><td>Medical complications</td><td>3</td><t...
<table><tr><td>Variable</td><td>PFNA (n = 72)</td><td>DHS (n = 70)</td><td>P value</td></tr><tr><td>Total complications</td><td>15</td><td>31</td><td>0.003</td></tr><tr><td>Patients affected</td><td>15 (20.8%)</td><td>31 (42.9%)</td><td>0.003</td></tr><tr><td>Medical complications</td><td>3</td><td>5</td><td>0.442</td>...
<table><tr><td>Variable</td><td>PFNA (n = 72)</td><td>DHS (n = 70)</td><td>P value</td></tr><tr><td>Periprosthetic fracture</td><td>3 (4.2%)</td><td>11 (15.7%)</td><td>0.021</td></tr><tr><td>Prosthetic instability</td><td>1</td><td>2</td><td>0.617</td></tr><tr><td>Dislocation</td><td>1</td><td>3</td><td>0.363</td></tr>...
a56bdd2457876e0c53975bc81be5c96aa15f16a05bd47f78f7e4eafb59194064.png
simple
<table><tr><td>WHO AFRO SLIPTA Checklist Audit Score Sheet (Section)</td><td>Total Points</td></tr><tr><td>Section 1: Documents &amp; Records</td><td>25</td></tr><tr><td>Section 2: Management Reviews</td><td>17</td></tr><tr><td>Section 3: Organization &amp; Personnel</td><td>20</td></tr><tr><td>Section 4: Client Manage...
<table><tr><td>WHO AFRO SLIPTA Checklist Audit Score Sheet (Section)</td><td>Total Points</td></tr><tr><td>Section 1: Documents & Records</td><td>25</td></tr><tr><td>Section 2: Management Reviews</td><td>17</td></tr><tr><td>Section 3: Organization & Personnel</td><td>20</td></tr><tr><td>Sect</td><td>8</td></tr></table>
<table><tr><td>ion 4: Client Management & Customer Service</td><td></td></tr><tr><td>Section 5: Equipment</td><td>30</td></tr><tr><td>Section 6: Internal Audit</td><td>10</td></tr><tr><td>Section 7: Purchasing and Inventory</td><td>30</td></tr><tr><td>Section 8: Process Control and Internal & External Quality Audit</td...
eaaf5ef211b002e6d45624dd8674d0882ec9a12054b10229d82a040d5955a40c.png
complex
<table><tr><td>Correlate</td><td>OR</td><td>95 % CI</td><td><i>p</i>-value</td></tr><tr><td colspan="4">Socio-demographic factors</td></tr><tr><td colspan="4"> Age</td></tr><tr><td>(base) 18&#8211;29</td><td>1.00</td><td></td><td></td></tr><tr><td>30&#8211;39</td><td>0.95</td><td>0.77,1.17</td><td>0.613</td></tr><tr><t...
<table><tr><td>Correlate</td><td>OR</td><td>95 % CI</td><td>p-value</td></tr><tr><td colspan="4">Socio-demographic factors</td></tr><tr><td colspan="4">Age</td></tr></table>
<table><tr><td>Correlate</td><td>OR</td><td>95 % CI</td><td>p-value</td></tr><tr><td>(base) 18–29</td><td>1.00</td><td></td><td></td></tr><tr><td>30–39</td><td>0.95</td><td>0.77,1.17</td><td>0.613</td></tr><tr><td>40–49</td><td>1.12</td><td>0.92,1.38</td><td>0.263</td></tr><tr><td>50–55</td><td>1.11</td><td>0.88,1.40</...
d5c196793d500ddbd135e7e4b663cedad54e5b8efe36a15542c74193966fa1fe.png
simple
<table><tr><td></td><td>Left hemisphere</td><td>Right hemisphere</td></tr><tr><td>V1</td><td></td><td></td></tr><tr><td>Smooth objects</td><td>0.92 &#177; 0.09</td><td>0.82 &#177; 0.09</td></tr><tr><td>Textured objects</td><td>1.63 &#177; 0.11</td><td>1.50 &#177; 0.13</td></tr><tr><td>V2</td><td></td><td></td></tr><tr>...
<table><tr><td></td><td>Left hemisphere</td><td>Right hemisphere</td></tr><tr><td>V1</td><td></td><td></td></tr><tr><td>Smooth objects</td><td>0.92 ± 0.09</td><td>0.82 ± 0.09</td></tr></table>
<table><tr><td></td><td>Left hemisphere</td><td>Right hemisphere</td></tr><tr><td>Textured objects</td><td>1.63 ± 0.11</td><td>1.50 ± 0.13</td></tr><tr><td>V2</td><td></td><td></td></tr><tr><td>Smooth objects</td><td>0.92 ± 0.06</td><td>0.88 ± 0.06</td></tr><tr><td>Textured objects</td><td>1.33 ± 0.07</td><td>1.28 ± 0....
86496f27884e5e8ff74e7da31f7c6e64679ee9d1c0f78294521fa57b6ab18bb1.png
complex
<table><tr><td colspan="2">Parameter</td><td>UM</td><td>SM</td><td>Total</td><td>RR (95% CI)</td><td><i>p</i>-value</td><td>&#967;<sup>2</sup></td><td><i>p</i>-value</td></tr><tr><td rowspan="4">Age</td><td>&lt;60</td><td>64 (61.5)</td><td>40 (38.5)</td><td>104 (42.7)</td><td>2.2 (1.3&#8211;3.7)</td><td>0.003</td><td r...
<table><tr><td colspan="2">Parameter</td><td>UM</td><td>SM</td><td>Total</td><td>RR (95% CI)</td><td>p-value</td><td>χ2</td><td>p-value</td></tr><tr><td rowspan="2">Age</td><td><60</td><td>64 (61.5)</td><td>40 (38.5)</td><td>104 (42.7)</td><td>2.2 (1.3–3.7)</td><td>0.003</td><td rowspan="2">9.326</td><td rowspan="2">0....
<table><tr><td colspan="2">Parameter</td><td>UM</td><td>SM</td><td>Total</td><td>RR (95% CI)</td><td>p-value</td><td>χ2</td><td>p-value</td></tr><tr><td rowspan="2">Age</td><td>120+</td><td>42 (71.2)</td><td>17 (28.8)</td><td>59 (24.2)</td><td>1.6 (0.8–3.0)</td><td>0.150</td><td rowspan="2">9.326</td><td rowspan="2">0....
f192539ddee8d0bf62253ac1c9512532e264150d2463124d777e3fbd5aceea1b.png
simple
<table><tr><td>Study</td><td>Main perspective</td><td>Subject</td><td>Method</td></tr><tr><td>Hansen, Hegrenes, Larsen, Sehested, &amp; Stokstad, 2005</td><td>Biological Economic</td><td>Financial impact of technical herd performance indicators</td><td>Mathematical and statistical modelling</td></tr><tr><td>Kristensen,...
<table><tr><td>Study</td><td>Main perspective</td><td>Subject</td><td>Method</td></tr><tr><td>Hansen, Hegrenes, Larsen, Sehested, & Stokstad, 2005</td><td>Biological Economic</td><td>Financial impact of technical herd performance indicators</td><td>Mathematical and statistical modelling</td></tr><tr><td>Kristensen, Øst...
<table><tr><td>Vaarst & Tind Sørensen, 2009</td><td>Biological Managerial</td><td>Dairy farmers’ perceptions and attitudes related to calf management</td><td>Semi-structured interviews</td></tr><tr><td>Van Asseldonk, Renes, Lam, & Hogeveen, 2010</td><td>Managerial</td><td>Farmers’ perceptions, intentions, actions and d...
862f5e92e2fc2c379835e45541620bb51d3adf9ee2d0422b906d50690110fe15.png
simple
<table><tr><td>Illumina cg ID</td><td>Chromosome</td><td>Genomic location</td><td>Gene<sup>a</sup></td><td>Gene region</td><td>HR (95 % CI)<sup>b</sup></td><td><i>P</i> value</td></tr><tr><td>cg15786837</td><td>17</td><td>46806935</td><td><i>HOXB13</i></td><td>TSS1500</td><td>1.86 (1.37&#8211;2.53)</td><td>6.97E-05</td...
<table><tr><td>Illumina cg ID</td><td>Chromosome</td><td>Genomic location</td><td>Genea</td><td>Gene region</td><td>HR (95 % CI)b</td><td>P value</td></tr><tr><td>cg15786837</td><td>17</td><td>46806935</td><td>HOXB13</td><td>TSS1500</td><td>1.86 (1.37–2.53)</td><td>6.97E-05</td></tr><tr><td>cg22030072</td><td>2</td><td...
<table><tr><td>Illumina cg ID</td><td>Chromosome</td><td>Genomic location</td><td>Genea</td><td>Gene region</td><td>HR (95 % CI)b</td><td>P value</td></tr><tr><td>8261841</td><td>7</td><td>82463</td><td>EM139</td><td></td><td></td><td>82E-04</td></tr><tr><td>cg02926307</td><td>12</td><td>106520198</td><td>NUAK1</td><td...
53f9dd1a7e9374a106d38d4b7f8b64879ac9be99661cbbd0ba04b2565e785a68.png
simple
<table><tr><td>Parameter</td><td>Value</td><td>Parameter</td><td>Value</td></tr><tr><td>Radio chip</td><td>CC 2420</td><td>TsRxWait</td><td>2.2 ms</td></tr><tr><td>Transmit power (0 dBm)</td><td>57.42 mW</td><td>TsAck (26 bytes)</td><td>0.832 ms</td></tr><tr><td>Receive power</td><td>62.04 mW</td><td>TsCCA</td><td>0.12...
<table><tr><td>Parameter</td><td>Value</td><td>Parameter</td><td>Value</td></tr><tr><td>Radio chip</td><td>CC 2420</td><td>TsRxWait</td><td>2.2 ms</td></tr><tr><td>Transmit power (0 dBm)</td><td>57.42 mW</td><td>TsAck (26 bytes)</td><td>0.832 ms</td></tr></table>
<table><tr><td>Parameter</td><td>Value</td><td>Parameter</td><td>Value</td></tr><tr><td>Receive power</td><td>62.04 mW</td><td>TsCCA</td><td>0.128 ms</td></tr><tr><td>Listen power</td><td>62.04 mW</td><td>TsRxTx (TxRx turnaround)</td><td>0.192 ms</td></tr><tr><td>TsMaxPacket (133 bytes)</td><td>4.256 ms</td><td></td><t...
8e7283b62387965d56efc301862b2d42730e429c1820729bb6d49ad17b7d777d.png
simple
<table><tr><td></td><td>RD CsA (<i>n</i> = 99)</td><td>ST CsA (<i>n</i> = 100)</td></tr><tr><td>Everolimus dose (mg/day)</td><td></td><td></td></tr><tr><td>Month 1</td><td>1.3 &#177; 0.5</td><td>1.4 &#177; 0.6</td></tr><tr><td>Month 6</td><td>1.4 &#177; 0.6</td><td>1.3 &#177; 0.5</td></tr><tr><td>Everolimus trough conc...
<table><tr><td></td></tr><tr><td>Everolimus dose (mg/day)</td></tr><tr><td>Month 1</td></tr><tr><td>Month 6</td></tr><tr><td>Everolimus trough concentration (ng/mL)</td></tr><tr><td>Month 1</td></tr><tr><td>Month 6</td></tr><tr><td>Cyclosporine dose (mg/kg/day)</td></tr><tr><td>Month 1</td></tr><tr><td>Month 6</td></tr...
<table><tr><td>RD CsA (n = 99)</td><td>ST CsA (n = 100)</td></tr><tr><td></td><td></td></tr><tr><td>1.3 ± 0.5</td><td>1.4 ± 0.6</td></tr><tr><td>1.4 ± 0.6</td><td>1.3 ± 0.5</td></tr><tr><td></td><td></td></tr><tr><td>5.8 ± 3.6</td><td>5.8 ± 2.5</td></tr><tr><td>4.8 ± 1.7</td><td>5.3 ± 2.3</td></tr><tr><td></td><td></td...
7d5006dd02e7d169db2f20b697fa6adc5c5e29c8fcf5267bbe63a00bdfc561be.png
simple
<table><tr><td></td><td>Overall, n (%) n = 1096</td><td>Male n (%) n = 460 (42.0)</td><td>Female n (%) n = 636 (58.0)</td><td><i>p</i>-Value</td></tr><tr><td>Age in years</td><td></td><td></td><td></td><td></td></tr><tr><td> 10&#8211;12</td><td>635 (57.9)</td><td>259 (56.3)</td><td>376 (59.1)</td><td></td></tr><tr><td>...
<table><tr><td></td><td>Overall, n (%) n = 1096</td></tr><tr><td>Age in years</td><td></td></tr><tr><td>10–12</td><td>635 (57.9)</td></tr><tr><td>13–14</td><td>461 (42.1)</td></tr><tr><td>Pubertal age (Tanner 1–5)</td><td></td></tr><tr><td>Tanner 1 or 2</td><td>509 (46.4)</td></tr><tr><td>Tanner stage >2</td><td>584 (5...
<table><tr><td>Male n (%) n = 460 (42.0)</td><td>Female n (%) n = 636 (58.0)</td><td>p-Value</td></tr><tr><td></td><td></td><td></td></tr><tr><td>259 (56.3)</td><td>376 (59.1)</td><td></td></tr><tr><td>201 (43.7)</td><td>260 (40.9)</td><td>0.351</td></tr><tr><td></td><td></td><td></td></tr><tr><td>217 (47.2)</td><td>29...
1f092d40640a75802a3954fa77e9f76bec4fd46eb789c0b2386ee4e890a2dae2.png
complex
<table><tr><td>Features</td><td colspan="4">Missense mutations identified as divergent variants based on the analysis of whole-genome sequence datasets from Churra and Australian Merino samples</td></tr><tr><td>SNP position (Oar_v3.1)</td><td>52,429,848</td><td>37,308,727</td><td>37,3557,21</td><td>37,356,400</td></tr>...
<table><tr><td>Features</td><td colspan="4">Missense mutations identified as divergent variants based on the analysis of whole-genome sequence datasets from Churra and Australian Merino samples</td></tr><tr><td>SNP position (Oar_v3.1)</td><td>52,429,848</td><td>37,308,727</td><td>37,3557,21</td><td>37,356,400</td></tr>...
<table><tr><td>Properties of mutant aminoacid</td><td>Hydrophilic, charge “+”</td><td>Hydrophobic, apolar, no charge</td><td>Hydrophobic, no charge</td><td>Hydrophilic,, charge “−”</td></tr><tr><td>Churra genotypes</td><td>TT (15)</td><td>CC (14), CT (1)</td><td>AT (1), TT (14)</td><td>AA (14), AT (1)</td></tr><tr><td>...
ba45bc2ec25ab07b7bb2150af4a9c90a351b622ac728ea76916d1dc14de52eb6.png
complex
<table><tr><td rowspan="2">SNPs</td><td rowspan="2">Alleles</td><td>CAD</td><td>Control</td><td rowspan="2">OR</td><td rowspan="2">95% CI</td><td rowspan="2"><i>p</i></td></tr><tr><td><i>n</i> (%)</td><td><i>n</i> (%)</td></tr><tr><td rowspan="2">rs6510599</td><td>C</td><td>324 (59.3)</td><td>157 (56.5)</td><td rowspan...
<table><tr><td rowspan="2">SNPs</td><td rowspan="2">Alleles</td><td>CAD</td><td>Control</td><td rowspan="2">OR</td><td rowspan="2">95% CI</td><td rowspan="2">p</td></tr><tr><td>n (%)</td><td>n (%)</td></tr><tr><td rowspan="2">rs6510599</td><td>C</td><td>324 (59.3)</td><td>157 (56.5)</td><td rowspan="2">1.125</td><td ro...
<table><tr><td rowspan="2">SNPs</td><td rowspan="2">Alleles</td><td>CAD</td><td>Control</td><td rowspan="2">OR</td><td rowspan="2">95% CI</td><td rowspan="2">p</td></tr><tr><td>n (%)</td><td>n (%)</td></tr><tr><td>rs3764640</td><td>T</td><td>314 (64.1)</td><td>168 (61.8)</td><td>1.104</td><td>0.813–1.500</td><td>0.531<...
ae605bf9827c48a61d3f2a2bc3d37ebf376b7fafbb1f9f2b4f2d0aa6043679e4.png
complex
<table><tr><td rowspan="2">Predictors of analgesia/sedation</td><td colspan="2">Univariate</td><td colspan="2">Multivariate</td></tr><tr><td><i>p</i>-value</td><td>OR (95% CI)</td><td><i>p</i>-value</td><td>OR (95% CI)</td></tr><tr><td>Gestational age (weeks) &#8804;32</td><td>&lt;.0001</td><td>3.54 (2.15&#8211;5.83)</...
<table><tr><td rowspan="2">Predictors of analgesia/sedation</td><td colspan="2">Univariate</td><td colspan="2">Multivariate</td></tr><tr><td>p-value</td><td>OR (95% CI)</td><td>p-value</td><td>OR (95% CI)</td></tr><tr><td>Gestational age (weeks) ≤32</td><td><.0001</td><td>3.54 (2.15–5.83)</td><td></td><td></td></tr><tr...
<table><tr><td rowspan="2">Predictors of analgesia/sedation</td><td colspan="2">Univariate</td><td colspan="2">Multivariate</td></tr><tr><td>p-value</td><td>OR (95% CI)</td><td>p-value</td><td>OR (95% CI)</td></tr><tr><td>Local guidelines for pain assessment</td><td>0.8953</td><td>1.10 (0.27–4.55)</td><td></td><td></td...
a836f240fc6017bb8b4f400a2abecf013bcf0e7ccbb08a5e0864e9d10d957a42.png
complex
<table><tr><td></td><td colspan="3">Control (<i>n</i> = 10)</td><td colspan="3">TP4 (<i>n</i> = 10)</td></tr><tr><td>Time (Day)</td><td>1</td><td>3</td><td>6</td><td>1</td><td>3</td><td>6</td></tr><tr><td>GOT (U/L)</td><td>42.1 &#177; 1.3 <sup>A</sup></td><td>44.2 &#177; 2.1 <sup>A</sup></td><td>41.6 &#177; 1.5 <sup>A<...
<table><tr><td></td><td colspan="3">Control (n = 10)</td><td colspan="3">TP4 (n = 10)</td></tr></table>
<table><tr><td>Time (Day)</td><td>1</td><td>3</td><td>6</td><td>1</td><td>3</td><td>6</td></tr><tr><td>GOT (U/L)</td><td>42.1 ± 1.3 A</td><td>44.2 ± 2.1 A</td><td>41.6 ± 1.5 A</td><td>102.1 ± 32.1 C</td><td>43.2 ± 1.5 A</td><td>45 ± 6.1 A</td></tr><tr><td>GPT (U/L)</td><td>45.2 ± 1.1 A</td><td>43.4 ± 4.3 A</td><td>46.1...
bb6dfe6c6a1c91865b69248672f6f2d7ba914f47f5cb8b75403d172365a73ebc.png
complex
<table><tr><td>Condition</td><td>Number (%) of cases</td><td colspan="2">Mean number of coded diagnoses by coding volume</td><td colspan="2">Mean number of coded diagnoses by employment status</td><td colspan="2">Hospital level</td></tr><tr><td></td><td></td><td>Low</td><td>High</td><td>Part time</td><td>Full time</td>...
<table><tr><td>Condition</td><td>Number (%) of cases</td><td colspan="2">Mean number of coded diagnoses by coding volume</td><td colspan="2">Mean number of coded diagnoses by employment status</td><td colspan="2">Hospital level</td></tr><tr><td></td><td></td><td>Low</td><td>High</td><td>Part time</td><td>Full time</td>...
<table><tr><td>Condition</td><td>Number (%) of cases</td><td colspan="2">Mean number of coded diagnoses by coding volume</td><td colspan="2">Mean number of coded diagnoses by employment status</td><td colspan="2">Hospital level</td></tr><tr><td></td><td></td><td>Low</td><td>High</td><td>Part time</td><td>Full time</td>...
d668c2c12b756fbbfaf75e637b0c8575ffbe3ef04b9f7e1768b07ecd447e198e.png
simple
<table><tr><td><i>Campylobacter</i> phage</td><td>CP68</td><td>CP75</td><td>CP84</td><td>CP7</td><td>CP83</td><td>CP21</td><td>IBB_35 <sup>a</sup></td></tr><tr><td>Infected strains</td><td>31 (255)</td><td>30 (255)</td><td>34 (255)</td><td>19 (255)</td><td>15 (255)</td><td>17 (255)</td><td>12 (90)<sup>a</sup></td></tr>...
<table><tr><td>Campylobacter phage</td><td>CP68</td><td>CP75</td><td>CP84</td><td>CP7</td><td>CP83</td><td>CP21</td><td>IBB_35 a</td></tr><tr><td>Infected strains</td><td>31 (255)</td><td>30 (255)</td><td>34 (255)</td><td>19 (255)</td><td>15 (255)</td><td>17 (255)</td><td>12 (90)a</td></tr><tr><td>% positive</td><td>12...
<table><tr><td>C. sputorum strains</td><td>0 (2)</td><td>0 (2)</td><td>0 (2)</td><td>0 (2)</td><td>0 (2)</td><td>0 (2)</td><td>0 (2)</td></tr><tr><td>% positive</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>C. hyointestinalis strains</td><td>0 (1)</td><td>0 (1)</td><td>0 (1)</td...
429c9f7f68bd19bf9525d01f4ec4c213b7e48ce1affd8763e63936ed5870622f.png
simple
<table><tr><td>Sample</td><td>Accession no.</td><td>ciHHV-6</td><td>Integration site<sup><i>a</i></sup></td><td>Population or country</td></tr><tr><td>LEI-1501<sup><i>b</i></sup></td><td>KT355575</td><td>A</td><td>19q</td><td>Leicester area (England)</td></tr><tr><td>HAPMAP NA18999</td><td>KY316047</td><td>A</td><td></...
<table><tr><td>Sample</td><td>Accession no.</td><td>ciHHV-6</td><td>Integration sitea</td><td>Population or country</td></tr><tr><td>LEI-1501b</td><td>KT355575</td><td>A</td><td>19q</td><td>Leicester area (England)</td></tr><tr><td>HAPMAP NA18999</td><td>KY316047</td><td>A</td><td></td><td>Japan</td></tr><tr><td>3A-10q...
<table><tr><td>BAN519f</td><td>KY316043</td><td>B</td><td></td><td>Banff (Scotland)</td></tr><tr><td>COR264f</td><td>KY316042</td><td>B</td><td></td><td>Cornwall (England)</td></tr><tr><td>CUM082f</td><td>KY316041</td><td>B</td><td></td><td>Cumbria (England)</td></tr><tr><td>DER512f</td><td>KY316040</td><td>B</td><td>J...
2398faa68e304276e811df9aa859ec52af6c58c824f2e1d69b8cef740a3615ce.png
complex
<table><tr><td colspan="2">Variable</td><td>Adjusted odds ratio</td><td>95% confidence interval</td></tr><tr><td>Age (years)</td><td>65-74 vs &lt;65</td><td>1.82</td><td>1.49, 2.23</td></tr><tr><td> </td><td>75-84 vs &lt;65</td><td>2.52</td><td>2.11, 3.02</td></tr><tr><td> </td><td>85+ vs &lt; 65</td><td>3.31</td><td>2...
<table><tr><td colspan="2">Variable</td><td>Adjusted odds ratio</td><td>95% confidence interval</td></tr><tr><td>Age (years)</td><td>65-74 vs <65</td><td>1.82</td><td>1.49, 2.23</td></tr><tr><td></td><td>75-84 vs <65</td><td>2.52</td><td>2.11, 3.02</td></tr></table>
<table><tr><td colspan="2">Variable</td><td>Adjusted odds ratio</td><td>95% confidence interval</td></tr><tr><td></td><td>85+ vs < 65</td><td>3.31</td><td>2.76, 3.95</td></tr><tr><td colspan="2">Female</td><td>1.14</td><td>1.04, 1.24</td></tr><tr><td>MAPLe score‡</td><td>2 vs 1</td><td>1.45</td><td>1.16, 1.81</td></tr>...
e0fd03b0292284788003ded461fb690db6f6265525e32ac8d39b9b8a6187cd92.png
complex
<table><tr><td>Items</td><td colspan="2">Low-Fps:Cps</td><td colspan="2">High-Fps:Cps</td><td></td><td colspan="3"><i>P</i>-value</td></tr><tr><td>FA, g/d</td><td>0</td><td>24</td><td>0</td><td>24</td><td>SEM</td><td>Fps:Cps</td><td>FA</td><td>(Fps:Cps) &#215; FA</td></tr><tr><td>CH<sub>4</sub>, L/d</td><td>23.14</td><...
<table><tr><td>Items</td><td colspan="2">Low-Fps:Cps</td><td colspan="2">High-Fps:Cps</td><td></td><td colspan="3">P-value</td></tr><tr><td>FA, g/d</td><td>0</td><td>24</td><td>0</td><td>24</td><td>SEM</td><td>Fps:Cps</td><td>FA</td><td>(Fps:Cps) × FA</td></tr><tr><td>CH4, L/d</td><td>23.14</td><td>15.80</td><td>22.84<...
<table><tr><td>e</td><td>11.93a</td><td>0.79b</td><td>10.82b</td><td>b</td><td>.170</td><td>0.303</td><td></td><td>0.026</td></tr><tr><td>A:P</td><td>4.89a</td><td>3.62b</td><td>3.74b</td><td>3.15c</td><td>0.095</td><td>< 0.001</td><td>< 0.001</td><td>0.048</td></tr></table>
e33a2891009a0e8f72f19e489746e466af3dc699f138a95bb38f6dff681513b2.png
simple
<table><tr><td>Case vignette</td><td>Respondents, <i>n</i></td><td>Rank sum</td></tr><tr><td>1</td><td>19</td><td>460.50</td></tr><tr><td>2</td><td>16</td><td>564.50</td></tr><tr><td>3</td><td>19</td><td>860.50</td></tr><tr><td>4</td><td>19</td><td>815.50</td></tr></table>
<table><tr><td>Case vignette</td><td>Respondents, n</td><td>Rank sum</td></tr><tr><td>1</td><td>19</td><td>460.50</td></tr><tr><td>2</td><td>16</td><td>564.50</td></tr><tr><td>3</td><td>19</td><td>860.50</td></tr></table>
<table><tr><td>Case vignette</td><td>Respondents, n</td><td>Rank sum</td></tr><tr><td>4</td><td>19</td><td>815.50</td></tr></table>
a41d3d12a17e122d02f007213adfac1d95712dc886aa8a383c8d683206ff5fc5.png
complex
<table><tr><td colspan="2">Collaborative Problem Solving Skills</td><td>N</td><td>Mean</td><td>Standard Deviation</td></tr><tr><td rowspan="3">Social Skills</td><td>Participation</td><td>210</td><td>3.07</td><td>1.316</td></tr><tr><td>Perspective Taking</td><td>210</td><td>3.09</td><td>1.347</td></tr><tr><td>Social Reg...
<table><tr><td colspan="2">Collaborative Problem Solving Skills</td><td>N</td><td>Mean</td><td>Standard Deviation</td></tr></table>
<table><tr><td rowspan="3">Social Skills</td><td>Participation</td><td>210</td><td>3.07</td><td>1.316</td></tr><tr><td>Perspective Taking</td><td>210</td><td>3.09</td><td>1.347</td></tr><tr><td>Social Regulation</td><td>210</td><td>3.10</td><td>1.364</td></tr><tr><td rowspan="2">Cognitive skills</td><td>Task Regulation...
7a06836b6455de3c37f08f5e25f2253f89ba8fe08d93086490566516734aeb1b.png
complex
<table><tr><td></td><td colspan="3">Recall</td></tr><tr><td></td><td>25 %</td><td>50 %</td><td>75 %</td></tr><tr><td>Precision to benign</td><td>82 %</td><td>66 %</td><td>52 %</td></tr><tr><td>Precision to malignant</td><td>86 %</td><td>74 %</td><td>62 %</td></tr><tr><td></td><td>Precision (<i>n</i>=30)</td><td></td><t...
<table><tr><td></td><td colspan="2">Recall</td></tr><tr><td></td><td>25 %</td><td>50 %</td></tr><tr><td>Precision to benign</td><td>82 %</td><td>66 %</td></tr><tr><td>Precision to malignant</td><td>86 %</td><td>74 %</td></tr><tr><td></td><td>Precision (n=30)</td><td></td></tr><tr><td>Benign</td><td>85 %</td><td></td></...
<table><tr><td>Recall</td></tr><tr><td>75 %</td></tr><tr><td>52 %</td></tr><tr><td>62 %</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr></table>
b7d43e2463d5d12ad42080f842ff6896ac63bb4f87f4bb752f0331ce574b0279.png
simple
<table><tr><td><i>Variable</i></td><td><i>Whole sample</i><i>N = 3033</i><i>n (%)</i></td><td><i>Public facilities</i><i>n = 2751</i><i>n (%)</i></td><td><i>Private facilities</i><i>n = 282</i><i>n (%)</i></td><td><i>P-Value</i></td></tr><tr><td>Age in years</td><td></td><td></td><td></td><td>&lt; 0.001</td></tr><tr><t...
<table><tr><td>Variable</td><td>Whole sampleN = 3033n (%)</td><td>Public facilitiesn = 2751n (%)</td><td>Private facilitiesn = 282n (%)</td><td>P-Value</td></tr><tr><td>Age in years</td><td></td><td></td><td></td><td>< 0.001</td></tr><tr><td>15-24</td><td>1444(48.4)</td><td>1378(50.9)</td><td>66(23.8)</td><td></td></tr...
<table><tr><td>Individual counselling</td><td>757(26.2)</td><td>624(22.9)</td><td>133(80.6)</td><td></td></tr></table>
69eadfa82d5352629f7ac0563062b4b331a4f1078ccf1b6501a4f97ae42cabd0.png
complex
<table><tr><td></td><td></td><td colspan="2"><underline>Factor Loadings</underline>*</td><td></td></tr><tr><td>Items</td><td></td><td>Benefits</td><td>Barriers</td><td>Unique Variance</td></tr><tr><td>Osteoporosis drug treatment benefits&#8224;</td><td></td><td></td><td></td><td></td></tr><tr><td>1</td><td>Drug treatme...
<table><tr><td></td><td></td><td colspan="2">Factor Loadings*</td><td></td></tr><tr><td>Items</td><td></td><td>Benefits</td><td>Barriers</td><td>Unique Variance</td></tr><tr><td>Osteoporosis drug treatment benefits†</td><td></td><td></td><td></td><td></td></tr><tr><td>1</td><td>Drug treatments can help to build strong ...
<table><tr><td></td><td></td><td colspan="2">Factor Loadings*</td><td></td></tr><tr><td>Items</td><td></td><td>Benefits</td><td>Barriers</td><td>Unique Variance</td></tr><tr><td>3</td><td>Drug treatments can cut down the chances of broken bones</td><td>0.87</td><td>0.10</td><td>0.25</td></tr><tr><td>6</td><td>You would...
554f5370c72b841105ab5ea44cb1d68aa159ec4f8c6c89219f861e32a6ef17f2.png
simple
<table><tr><td></td><td>&#946;</td><td>S.E.</td><td>OR</td><td>CI 95%</td><td>p-value</td></tr><tr><td>Pulse oximetry (SpO2 &lt; 95%)</td><td>1.39</td><td>0.63</td><td>4.02</td><td>1.16&#8211;13.85</td><td>0.022</td></tr><tr><td>Clinical stage (III vs. IV)</td><td>0.78</td><td>0.43</td><td>2.18</td><td>0.93&#8211;5.06<...
<table><tr><td></td><td>β</td><td>S.E.</td><td>OR</td><td>CI 95%</td><td>p-value</td></tr><tr><td>Pulse oximetry (SpO2 < 95%)</td><td>1.39</td><td>0.63</td><td>4.02</td><td>1.16–13.85</td><td>0.022</td></tr><tr><td>Clinical stage (III vs. IV)</td><td>0.78</td><td>0.43</td><td>2.18</td><td>0.93–5.06</td><td>0.070</td></...
<table><tr><td></td><td>β</td><td>S.E.</td><td>OR</td><td>CI 95%</td><td>p-value</td></tr><tr><td>Appetite (10 mm)</td><td>0.13</td><td>0.06</td><td>1.14</td><td>1.01–1.30</td><td>0.041</td></tr><tr><td>Fatigue (10 mm)</td><td>0.21</td><td>0.09</td><td>1.23</td><td>1.03–1.47</td><td>0.019</td></tr></table>
7dd550311a2318e65e05d61c1ac9a84feea99232a0f34a2ea0b955e77ac2105d.png
complex
<table><tr><td>Responders</td><td>Biofeedback group</td><td>Control group</td></tr><tr><td colspan="3">T2</td></tr><tr><td><i>n</i> (%)</td><td>10 (67 %)</td><td>2 (17 %)</td></tr><tr><td colspan="3">T3</td></tr><tr><td><i>n</i> (%)</td><td>12 (80 %)</td><td>3 (25 %)</td></tr><tr><td colspan="3">T4</td></tr><tr><td><i>...
<table><tr><td>Responders</td><td>Biofeedback group</td><td>Control group</td></tr><tr><td colspan="3">T</td></tr></table>
<table><tr><td colspan="3">2</td></tr><tr><td>n (%)</td><td>10 (67 %)</td><td>2 (17 %)</td></tr><tr><td colspan="3">T3</td></tr><tr><td>n (%)</td><td>12 (80 %)</td><td>3 (25 %)</td></tr><tr><td colspan="3">T4</td></tr><tr><td>n (%)</td><td>7 (47 %)</td><td>2 (17 %)</td></tr></table>
da7e76bca195dff9e0ad941f157387d5ad59e69dde6ec14c57e336c172165bfd.png
complex
<table><tr><td> </td><td colspan="5">Category</td></tr><tr><td>Occupation</td><td>Documentation (N = 38) fraction %</td><td>Interactions (N = 36) fraction %</td><td>Adverse effects (N = 16) fraction %</td><td>Pregnancy and breastfeeding (N = 9) fraction %</td><td>Contraindications (N = 1) fraction %</td></tr><tr><td>Ph...
<table><tr><td></td><td colspan="5">Category</td></tr><tr><td>Occupation</td><td>Documentation (N = 38) fraction %</td><td>Interactions (N = 36) fraction %</td><td>Adverse effects (N = 16) fraction %</td><td>Pregnancy and breastfeeding (N = 9) fraction %</td><td>Contraindications (N = 1) fraction %</td></tr><tr><td>Phy...
<table><tr><td></td><td colspan="5">Category</td></tr><tr><td>Occupation</td><td>Documentation (N = 38) fraction %</td><td>Interactions (N = 36) fraction %</td><td>Adverse effects (N = 16) fraction %</td><td>Pregnancy and breastfeeding (N = 9) fraction %</td><td>Contraindications (N = 1) fraction %</td></tr><tr><td>the...